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ROLE OF REPLICATION PROTEIN A (RPA) AND PROLIFERATING CELL 
NUCLEAR ANTIGEN (PCNA) IN HUMAN DNA MISMATCH REPAIR  
 
    PCNA and RPA are required for DNA mismatch repair (MMR), but their roles 
in the pathway are not fully understood. Using an affinity pull-down approach, we 
show that (1) increased PCNA binding to DNA heteroduplexes is associated with 
the appearance and accumulation of excision products; and (2) RPA 
phosphorylation occurs when DNA polymerase δ binds to the DNA substrate. We 
therefore hypothesize that PCNA plays an important role in mismatch-provoked 
excision and that RPA phosphorylation plays an important role in DNA resynthesis. 
To determine the role of PCNA in MMR, mismatch-provoked and nick-directed 
excision was assayed in a cell-free system in the presence of the PCNA inhibitor, 
p21CIP1/WAF. We show that whereas PCNA is essential for 3’ directed excision, it is 
dispensable for the 5’ directed reaction, suggesting a differential role for PCNA in 
MMR. We further find that the PCNA-dependent pathway is the only pathway for 
3’ directed excision, but there are at least two pathways for 5’ directed excision, 
one of which is a PCNA-independent 5’ excision pathway. To determine if RPA 
phosphorylation facilitates DNA resynthesis, a gap-filling assay was developed 
using both a cell-free system and a purified system, and we demonstrate that RPA 
phosphorylation stimulates DNA polymerase δ-catalyzed resynthesis in both
systems. Kinetic studies indicate that phosphorylated RPA has a lower affinity for 
DNA compared with un-phosphorylated RPA. Therefore, the stimulation of 
resynthesis by phosphorylated RPA is likely due to the fact that phosphorylation 
promotes the release of RPA from DNA, thereby making DNA template available 
for resynthesis. 
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CHAPTER 1. DNA Mismatch Repair and Genomic Stability 
 
1.1 Introduction 
    Because DNA is the genetic material of most organisms, maintaining its stability is 
important for both an individual and for the species. The integrity of genetic information 
depends on the fidelity of DNA replication and on the efficiency of several different DNA 
repair pathways. Un-repaired replication errors and DNA damage induced by endogenous 
or exogenous agents, such as reactive oxygen species and adduct-forming carcinogens, 
might cause gene mutations and enhance genomic instability. Human cells contain many 
genomic maintenance pathways that safeguard genomic stability by correcting errors of 
normal DNA metabolism, and repairing DNA damage caused by endogenous or 
exogenous reactive agents. In last several decades, nucleotide excision repair, base 
excision repair, double-strand break repair, and mismatch repair (MMR) pathways have 
been identified in human cells [1-9]. Deficiency of any one of these repair pathways 
might lead to gene mutations and eventually to cancer and other human diseases [10, 11].  
  The MMR pathway plays an important role in maintaining genomic stability in 
almost all living organisms, from bacteria to humans [12-14]. It improves genomic 
stability through two important mechanisms: one is to correct base mispairs generated 
during DNA replication and recombination [6, 7, 15], and the other is to mediate DNA 
damage response, including cell cycle checkpoints [16-22] and programmed cell death or 
apoptosis [1, 9, 17, 21, 23]. The importance of the MMR system in genome stability is 
underscored by the fact that defects in this system have been shown to be the pathological 
basis of hereditary non-polyposis colorectal cancer (HNPCC) and certain types of 
sporadic cancers [2, 6, 8].  
 
1.2 Molecular mechanism of MMR in Escherichia coli 
1.2.1 Biochemical process of MMR 
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The DNA MMR system in Escherichia coli is reasonably well characterized [24-29], 
and the entire repair reaction has been reconstituted in vitro by using purified proteins. 
The eleven proteins required for MMR in E. coli are listed in Table 1.1. As described in 
Figure 1.1, the mechanism of MMR in E. coli this reaction can be generally divided into 
three steps: initiation, excision, and DNA resynthesis. MutS homodimer recognizes the 
mismatch and recruits MutL homodimer to form an initiation complex. By a mechanism 
that is still poorly understood (see below for details), the latent endonuclease MutH is 
loaded onto DNA at a nearby hemimethylated GATC site, which could be located as far 
as 1 kb either 3’ or 5’ to the mismatch, and activated by MutL. The activated MutH 
incises the daughter unmethylated DNA strand at the GATC site. The resulting single 
strand break is utilized to initiate mismatch-provoked excision. 3’→5’ mismatch excision 
is performed by ExoI or ExoX, while 5’→3’ mismatch excision is performed by ExoVII 
or RecJ. Excision in either direction requires DNA helicase II (UvrD) and single strand 
DNA binding protein (SSB). DNA resynthesis is performed by the DNA polymerase III 
holoenzyme in concert with the single strand DNA binding protein SSB. The remaining 
nick is sealed by DNA ligase.  
 
 
 
 
 
 
 
 
 
 
 
Table 1.1 Components of DNA MMR in E.coli and Human Cells 
Human 
MutSα, MutSβ 
MutLα 
? 
? 
Exo1,  
RPA 
Pol δ 
? 
PCNA, RFC 
HMGB1 
E.coli 
MutS 
MutL 
MutH 
UvrD 
ExoI, ExoVII, ExoX, RecJ
SSB 
Pol III holoenzyme 
DNA ligase 
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1.2.2 Current models for initiation and excision of MMR in E.coli 
    Mismatch recognition by MutS and MutL is the first step in removal of an errant 
base by the MMR pathway. An important question that has yet to be answered is how 
mismatch recognition is coupled to strand excision. In other words, once the MMR 
initiation factors are bound to the mismatch, how do these proteins signal the excision of 
the newly replicated strand that can begin up to 1 kb away from the mismatch? So far, 
there have been three models proposed to explain the coupling of mismatch recognition 
to strand excision, and all of these models have the common feature of involving MutS 
and MutL proteins and their ATPase activity [30-33]. 
The ATP-dependent translocation model. This model (Figure 1.2 A), proposed by 
Modrich and co-workers, was developed from observations made by electron microscopy 
of E. coli MutS bound to heteroduplex DNA in the presence and absence of ATP [34]. In 
this model, MutS binding to a mismatch does not require ADP, although the presence of 
ADP increases the mismatch binding specificity. ATP binding to MutS stimulates 
dissociation of MutS from the mismatch, and ATP hydrolysis provides the energy for 
translocation of DNA through MutS. The result is that MutS extrudes DNA to form an 
Ω-shaped DNA loop with the mismatch located within the loop. Then MutS-MutL 
Figure 1.1 The steps of DNA MMR in E.coli.  
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stimulates the endonuclease activity of MutH which binds to hemimethylated GATC site.  
The sliding clamp model. The sliding clamp model was proposed by Fishel and 
co-workers [35]. In this model (Figure 1.2 B), MutS is thought to exist in ADP-bound and 
ATP-bound forms. The MutS-ADP form has a high affinity for a mismatch. Binding of 
ADP-bound MutS to a mismatch provokes ADP→ATP exchange. The exchange causes a 
conformational change in MutS so as to reduce its affinity for the mismatch. Now the 
MutS-ATP diffuses bidirectionally along the DNA duplex as an ATP 
hydrolysis-independent “sliding clamp”. MutL interacts with ATP-bound MutS sliding 
clamps and diffuses along the DNA. After the MutS-MutL complex reaches a 
hemimethylated GATC site, the MutH endonuclease is activated to make a strand break.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. 2 The models for mismatch recognition and subsequent repair events. (A) ATP-dependent 
translocation model. (B) Sliding clamp model. Different color MutS represents its loading on DNA at 
different time. (C) The induced fit model. The panels are reproduced according to [1-3] 
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    The induced fit model. This model (Figure 1.2 C), proposed by Yang and co-workers, 
is based on observations made from the crystal structure analysis of bacterial MutS 
proteins bound to DNA containing a mismatch [36]. In this model, they argued that the 
MutS-mismatch initiation complex also serves as a signal for subsequent repair events 
through direct protein-protein interactions with other MMR proteins, such as MutL and 
MutH. ATP has two functions in this model: increasing repair specificity, and stimulating 
MutS-MutL complex formation (Figure 1.2 C Bottom panel). ATP binding dramatically 
reduces MutS affinity for homoduplex DNA (Figure 1.2 C Top panel) [37] and allows 
MutS to have a productive interaction with MutL, which links the mismatch-bound MutS 
and the hemimethylated GATC-bound MutH together to activate MutH [31, 38, 39].  
    Whereas the first two models emphasize that MutS moves away from the mismatch 
after the initial binding, the third model suggests that the mismatch recognition protein 
never leaves the mismatch.   
 
1.3 Molecular mechanism of MMR in human cells 
The MMR pathway is highly conserved through evolution as similar mechanisms 
and components are used in prokaryotic and eukaryotic cells. Thus, the E.coli MMR 
pathway has been utilized as a model for eukaryotic MMR. In human cells, five MutS 
homologs (MSH2, MSH3, MSH6, MSH4, and MSH5) [40-43] and four MutL homologs 
(MLH1, MLH3, PMS2, and PMS1) [44-46] have been identified. While MutS and MutL 
in E.coli function as homodimers, the human MutS and MutL homologous proteins act as 
heterodimers. MSH2 interacts with MSH6 and MSH3 to form MutSα and MutSβ, 
respectively; and MLH1 forms heterodimers with PMS2 (MutLα), PMS1 (MutLβ), or 
MSH3 (MutLγ). However, previous studies have shown that only MutSα, MutSβ and 
MutLα are involved in strand-specific MMR [41, 42, 44]. Other homologous proteins 
identified to be required in human MMR are exonuclease 1 (Exo1) [47-49], DNA 
polymerase δ [50], and replication protein A (RPA) [51, 52]. Very recently, proliferating 
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cell nuclear antigen (PCNA), replication factor C (RFC), and high mobility group box 1 
protein (HMGB1) have been implicated in human MMR  [53-59]. Although a MutH 
homolog has not been identified, human MMR can be directed by a pre-existing strand 
break either 5’ or 3’ to the mismatch in vitro [60].  
 
1.3.1 Mismatch recognition 
    As in E.coli, mismatch recognition in human cell is conducted by MutS and MutL 
homologs. MutSα preferentially recognizes base-base mismatches and 1-bp 
insertion/deletion loop (IDL) [41], while MutSβ preferentially recognizes IDL containing 
up to 16 extra nucleotides in one strand [42]. MutLα can associate with either a MutSα- 
or MutSβ-initiated reaction, and participates in the repair of either base-base or IDL 
mispairs [61]. However, a recent study shows that 5’ nick-directed mismatch excision can 
occur in the absence of MutLα, which indicates that MutLα might play a different role in 
3’ nick versus 5’ nick-directed MMR [49, 62]. MutS, MutL and their homologs have 
ATPase activity, which is important for both dimerization and mismatch recognition [36, 
56, 63, 64].  
Recent evidence suggests that PCNA, a homotrimeric ring, is also involved in the 
initiation step of human MMR. PCNA is found to physically interact with MSH6 and 
MSH3 [58, 65, 66], and to transfer MutSα to the mismatched site [67]. The sliding clamp 
model for MMR initiation has been demonstrated by several groups in human cells as 
well as in yeast [68-71].  
 
1.3.2 Mismatch-provoked excision 
No MutH homolog has yet been identified in human cells. Therefore, the mechanism 
through which strand discrimination occurs in human MMR repair is unknown at the 
present time. Despite this fact, it has been shown that strand break 3’ or 5’ to the 
mismatch is capable of directing strand-specific MMR in vitro nuclear extract from 
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human cell [60].  
    Human exonuclease 1 (Exo1) is a 5’ → 3’ exonuclease and demonstrates a 
specificity for double-stranded DNA. It can interact with MSH2, and MLH1 [47, 48, 72, 
73]. To date, it is the only nuclease that has been reported to be involved in human MMR. 
Surprisingly, recent reconstitution experiments indicate that Exo1 can perform both 
5’→3’ and 3’→5’ mismatch excision [49, 59, 62]. For heteroduplexes containing a strand 
break 5’ to mismatch, excision only requires MutSα, RPA and Exo1 [62]. Excision for 
heteroduplexes with a 3’ strand break requires three additional components, MutLα, 
PCNA and RPA [59].  
Exo1 null mutants in yeast and mice are only partially defective in MMR [74-76]. 
Consistent with the genetic studies, we have recently shown that HeLa nuclear extract 
contains a 5’→3’ PCNA-dependent mismatch excision activity, and this activity cannot 
be replaced by Exo1 [57]. Taken together, these studies suggest that as in E.coli, multiple 
nucleases are involved in eukaryotic MMR. 
Replication protein A (RPA) forms a stable heterotrimeric complex: 70kD (RPA1), 
32kD (RPA2), and 14kD (RPA3). Acting as a single strand DNA binding protein, RPA is 
required for DNA replication, DNA repair, and recombination [77, 78]. Recent studies 
have implicated that RPA is involved in MMR by both protecting the template DNA 
strand from the attack of nucleases and stimulating mismatch-provoked excision [52, 59, 
62]. 
In addition, HMGB1 also serves as a functioning component of human mismatch 
excision. This protein interacts with MutSα to stimulate the excision of both 3’and 5’ 
nick-containing heteroduplex DNA [53].  
 
1.3.3 DNA resynthesis 
    The DNA resynthesis and ligation steps in human MMR have not been reconstituted 
in vitro. The results from a cell free system have shown that DNA polymerase δ [50], 
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PCNA [56], and RPA [52] participate in the DNA resynthesis step. DNA polymerase δ is 
composed of four subunits: p125, p66, p50, and p12 [79-81]. It is responsible for DNA 
replication at both leading and lagging strands. Modrich and co-workers confirmed that 
polymerase δ is required for the repair of 3’ and 5’ mismatch substrates [50]. As a 
cofactor of DNA polymerases δ and ε, PCNA increases the processivity of these enzymes 
[56, 82, 83]. The requirement for PCNA in DNA resynthesis step of MMR is confirmed 
by a cell free system [56]. In addition to functioning in mismatch excision, RPA also 
plays a role in the DNA resynthesis step, through which RPA binds to ssDNA (template) 
generated during mismatch excision to protect it from nucleases digestion [52].  
 
1.4 The DNA MMR system mediates DNA damage response 
In addition to its role in correcting base mismatches, the human MMR system is able 
to maintain genomic stability by mediating DNA damage signaling [9]. In both E.coli and 
human cells, MMR deficient cells are less sensitive to certain mutagens, i.e., alkylating 
agents such as N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) and N-methyl-N- 
nitrosourea (MNU) [84, 85]. In addition, MMR deficient tumor cell lines are also 
resistant to chemotherapeutic drugs, i.e., cisplatin, procarbazine, and temozolomide 
[86-89]. All of this information suggests that the DNA MMR system may play a role in 
sensing DNA damage induced by chemicals, and triggering subsequent cell death. It has 
been reported that MutS and its homologs bind to many kinds of DNA adducts generated 
by cisplatin [90], N-acetyl-2-aminofluorene (AAF) and 2-aminofluorene (AF) [91], 
benzo[α]pyrene dihydrodiol epoxide and benzo[c]pyrene dihydrodiol epoxide [23, 92], 
and malondialdehyde [93].  
The mechanism how the MMR system mediates cell apoptosis induced by DNA 
damage is not fully understood. According to Toft et al. [94], p53 is a primary mediator 
of MMR-dependent apoptosis and other mediators function only in the case when p53 is 
deficient. However, Gong et al. showed that p73, but not p53, is involved in the 
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cisplatin-induced apoptotic response, and this process is also dependent on c-Abl tyrosine 
kinase activity [95, 96]. Recent studies showed that DNA damage results in stabilization 
of MLH1 by ATM (ataxia-telangiectasia mutated protein kinase) [97], and a high level of 
MLH1 in a cell can induce apoptosis [98, 99].  
Another DNA damage response mediated by MMR system is cell cycle arrest. It has 
been reported that MSH2 and MLH1 are required for G2/M and S phase checkpoint 
activation [16-20] through ATM, ATR, and p38 mitogen-activated protein kinase 
pathways [17, 21, 22], but the molecular mechanism is unclear. 
 
1.5 Research Objectives 
Although it has been shown that MutSα, MutLα, Exo1, PCNA, RFC, RPA, Pol δ 
and HMGB1 participate in DNA MMR, the detailed molecular mechanism of the human 
MMR reaction is not fully understood. Recently, PCNA is found to physically interact 
with MSH6 and MSH3 [58, 65, 66], and to transfer MutSα to the mismatched site [67]. 
However, mismatch recognition by MutSα does not depend on PCNA [41]. Given these 
observations, how to address the role for PCNA in the initiation step of MMR? In 
addition, Fotedar and Roberts demonstrate that the second subunit of RPA (RPA2) is 
phosphorylated during DNA replication [100]. RPA2 phosphorylation also occurs in 
response to DNA damage [101-105]. As one of important components of human MMR 
system, is RPA2 phosphorylated during MMR process? If yes, what is the role of RPA2 
phosphorylation in DNA MMR?    
These questions constitute the aims of this thesis. 
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CHAPTER 2. Materials and Methods 
 
2.1 Basic techniques 
2. 1.1 Chemicals and reagents 
Amersham: Streptavidin-sepharose, Hybond-NX, ECL Detection Reagent, Sephacry 
S-300 
Calbiochem: Hydroxylapatite 
DIFCO: LB Broth, Bacto-agar, 2×YT (Yeast Extract) 
Dupont: γ-32Pi-ATP, α-32Pi-dCTP 
FisherBiotech: 1-Butanol, Iso-propanol, KH2PO4 (Potassium Phosphate Momobasic), 
K2HPO4 (Potassium Phosphate Dibasic), NaH2PO4 (Sodium Phosphate Momobasic), 
Na2HPO4 (Sodium Phosphate Dibasic), SDS (Sodium Dodecyl Dulfate), Potassium 
Acetate, Tween-20, P.E.G.8000, NaOH (Sodium Hydroxide), KOH (Potassium 
Hydroxide) 
New England Biolab: restriction enzymes, Klenow fragment DNA polymerase, etc. 
Oncogen: MLH1, MSH2, PCNA, RPA70, and RPA32 monoclonal antibodies 
Roche: ATP (Adenosine Triphosphate), dNTP (deoxy Nucleotides Triphosphate), DTT 
(Dithiothreitol), Nonidet P-40,  
Sigma: Acrylamide, Aphidicolin, Boric Acid, Biotin-dATP, Sodium Citrate, MgCl2 
(Magnesium Chloride), NaCl (Sodium Chloride), KCl (Potassium Chloride), Triton 
X-100, N, N’-Methhylene-bis-Acrylamide, Polyvinylpyrrolidone, Wortmannin 
Transduction Laboratories: DNA polymerase δ (125kD subunit) monoclonal antibody 
USB: Ammonium Sulfate, Ammonium Persulfate, Agarose, CsCl (Cesium Chloride), 
ExoV, EDTA, Ethidium Bromide, Glycine, HEPES, Urea, T4-PNK, Tris, Phenol, etc. 
 
2. 1.2 Preparation of buffers  
    All solutions and cell culture media were prepared using de-ionized distilled water 
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(ddH2O). Solutions were sterilized either by filtering through a 0.22 µm filter or were 
autoclaved for 15 min at 121ºC. 
 
2.1.3 Agarose gel electrophoresis 
    Agarose gel electrophoresis was run in TAE (Tris/Acetate/EDTA) buffer containing 
40 mM Tris-Acetate and 2 mM EDTA. DNA samples were prepared for analysis by the 
addition of 6×agarose gel loading buffer containing 40% (w/v) sucrose, 0.5% (v/v) 
xylene cyanol, 0.05% (v/v) bromophenol blue, 20 mM EDTA and 0.2% sodium dodecyl 
sulfate (SDS). After running, gels were stained for 20 min using a solution of 0.5 µg/ml 
ethidium bromide (EtBr) in ddH2O and then rinsed for 20 min in ddH2O. Gels were 
visualized on an ultraviolet transilluminator. The images were captured using the Kodak 
Image Station 2000R system.  
 
2.1.4 Urea-PAGE gel and Southern blot 
    The required concentration of a polyacrylamide gel (usually 6%, 
acrylamide:bis-acrylamide = 19:1) containing 8 M urea was prepared in 1×TBE buffer 
(89 mM Tris, 89 mM boric acid and 2 mM EDTA). Samples to be run on the gel were 
heated at 95°C for 5 min after adding 3×SSCP (Single-strand conformation 
polymorphism) loading buffer (95% (v/v) formamide, 0.075% (v/v) xylene cyanol, 
0.075% (v/v) bromophenol blue, 20 mM EDTA), and then put on ice for 2 min. After 
electrophoresis, DNA was electro-transferred to Hybond-NX in 0.5×TBE. The membrane 
was dried at 37°C for 30 min and exposed to UV for 5 min to cross-link the DNA to the 
membrane. After pre-hybridization with hybridization buffer (2% SDS, 0.5% 
poly-Vinylpyrrolidone, 0.2% Heparin, 1 M NaCl, 1 mM EDTA, 50 mM Tris-HCl pH 7.5), 
the membrane was hybridized with 32Pi end-labeled probe at 37°C for 15 hr. The 
membrane was washed with 2×SSC/0.1%SDS (20×SSC buffer containing 3M sodium 
chloride and 0.3M sodium citrate, pH 7.0), 1×SSC/0.1%SDS, and 0.1×SSC/0.1%SDS, 
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respectively. The membrane was dried at room temperature, and exposed to X-ray film. 
 
2.1.5 SDS-PAGE gel and Western blot 
Slab gels containing an 8% acrylamide separating gel (0.375 M Tris-HCl pH 8.8, 
0.1% SDS) and 4% acrylamide stacking gel (0.125 M Tris-HCl pH 6.8, 0.1% SDS) were 
prepared from a 40% acrylamide stock solution (acrylamide: bis-acrylamide = 37.5:1). 
The samples were prepared by adding 3×loading buffer (120 mM Tris-HCl pH 6.8, 15% 
Mercaptoethanol, 3% SDS, and 10% Glycerol, and 0.075% Bromphenol Blue) and 
heated at 95°C for 3 min. After loading, the gel was run at 100 volts in gel-running buffer 
(0.025 M Tris, 0.2 M Glycine, 0.1% SDS). 
Western blot was performed in the following way. The proteins were 
electro-transferred onto nitrocellulose membrane in transfer buffer (200 ml/L methanol, 
3.03 g/L Tris, and 14.4 g/L glycine) using a BioRad electrotransfer apparatus. The 
membrane was then blocked in 5% milk dissolved in washing buffer (10 mM Tris-HCl 
pH 7.5, 0.8% NaCl, and 0.1% Tween-20) at RT for 30 min, followed by hybridization 
with the primary antibody and secondary antibody (the membrane was washed twice 
before changing antibody at RT with washing buffer). The membrane was dried and then 
treated with ECL Detection Reagent.  
 
2.2 Preparation of protein(s) and cell nuclear extract 
2.2.1 Preparation of cell nuclear extract 
    HeLa S3 cells were purchased from the National Cell Culture Center (Minneapolis, 
MN). N6 and H6 cells were cultured in DMEM medium containing 10% FBS. 
    Preparation of nuclear extract was performed at 4ºC or on ice as described 
previously [106]. The cultured cells were collected by centrifugation in a RC-3B 
centrifuge at 3200 rpm (3000 g) for 8 min. The cells were resuspended in washing buffer 
(20 mM Hepes pH 7.5, 5 mM KCl, 0.5 mM MgCl2, 0.2 M Sucrose, 0.5 mM DTT, 1× 
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proteinase inhibitors) and centrifuged at 4500 rpm (3300 g) for 5 min. The washed cells 
were treated with hypotonic buffer (20 mM Hepes pH 7.5, 5 mM KCl, 0.5 mM MgCl2, 
0.5 mM DTT, 1×proteinase inhibitors, 2.78 ml/g cell pellet) on ice for 10 min. The cells 
were then lysed by a Dounce homogenizer on ice to release nuclei (about 13 strokes using 
a B pestle). The nuclei were collected by centrifugation using a Beckman SS-34 rotor at 
4ºC (4100 rpm, 2000 g) for 5 min. The nuclear pellet was resuspended in cold extraction 
buffer (20 mM HEPES pH 7.5, 10% sucrose, 0.5 mM DTT, 1×proteinase inhibitors, 1.39 
ml/g cell pellet). After adding 0.031 volumes of 5 M NaCl stock solution, the 
resuspended nuclei were extracted on a rotating rack for 60 min in the cold room. The 
nuclear debris was separated by centrifugation in the SS-34 rotor at 4ºC (11,000 rpm, 
14,500 g) for 20 min. The nuclear proteins in the supernatant were precipitated with 
ammonium sulfate (0.42 g/ml) by slowly adding and slowly stirring the solution for 20 
min on ice. The proteins precipitated by ammonium sulfate were pelleted by 
centrifugation in the SS-34 rotor at 4ºC (11,500 rpm, 15,800 g) for 20 min. The 
supernatant was removed as much as possible, and the pellet was resuspended in dialysis 
buffer (25 mM HEPES pH 7.6, 50 mM KCl, 0.1 mM EDTA, 2 mM DTT, 1×proteinase 
inhibitors). The slurry was transferred into a dialysis bag. Dialysis was finished when the 
conductivity of sample approached 50 µS/cm (10µl sample into 4 ml ddH2O). The extract 
was clarified by centrifugation at 14,000 rpm for 20 min at 4ºC.  
 
2.2.2 Purification of PCNA, p21, p21-C and p21-N 
    Constructs for the bacterial overexpression of human N-terminal, 6-His-tagged 
PCNA, and human N-terminal 6-His-tagged p21Cip1/ WAF were generously provided by Dr. 
Jerald Hurwitz (Memorial Sloan-Kettering Cancer Center, New York, NY) and Dr. Yue 
Xiong (U. North Carolina, Chapel Hill, NC), respectively. These proteins were 
overexpressed in E.coli BL21 DE3 (pLysS) and BL21 DE3 cells, respectively, and 
purified to homogeneity as previously described [107, 108]. Constructs for the 
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overexpression of the N and C-terminal domains of p21Cip1/WAF fused to GST were 
generously provided by Dr. Anindya Dutta (U. of Virginia). The residues includeded in 
p21N and p21C fusion proteins were GST(1–218)-SDP-p21(1–90) and 
GST(1–218)-SDPM-p21(87–164), respectively.  These proteins were overexpressed in E.coli 
BL21 DE3 (pLysS) cells and purified to homogeneity using anion exchange and 
glutathione sepharose chromatography [109, 110]. Before use, all proteins were 
centrifuged at 16,000×g for 15 min to remove pallet, and the concentrations of the protein 
in solution were determined from UV absorbance.  
 
2.2.3 Purification of RPA2WT, RPA2A, and RPA2D 
    Constructs for the bacterial overexpression of human RPA2WT (p11d-tRPA32), 
RPA2A (p11d-tRPA32 S,T (1-39)A), and RPA2D (p11d-tRPA32 Asp8) were generously 
provided by Dr. Marc Wold (Dept of Biochemistry, University of Iowa). These proteins 
were overexpressed in E. coli BL21 DE3 cells, and purified to homogeneity as previously 
described [111]. Cell lysate from an induced culture was applied to an Affi-Gel Blue 
(Bio-Rad) column equilibrated with HI buffer (30 mM HEPES (from 1 M stock at pH 
7.8), 1 mM DTT, 0.25 mM EDTA, 0.25% (w/v) inositol, and 0.01% (v/v) NP-40) 
containing 50 mM KCl. The column was washed sequentially with HI buffer containing 
50 mM KCl, 0.8 M KCl, 0.5 M NaSCN, or 1.5 M NaSCN. The peak of protein from the 
1.5 M NaSCN wash (containing RPA) was applied directly to a Hydroxylapatite (HAP) 
column equilibrated with HI buffer with 30 mM KCl. The HAP column was washed 
sequentially with HI buffer containing 0, 80, or 500 mM potassium phosphate. RPA was 
eluted in the 80 mM potassium phosphate fraction. This fraction was then diluted into HI 
buffer without KCl to reduce the ionic strength below 100 mM and then applied to a 
Mono-Q column equilibrated with HI buffer containing 50 mM KCl. The column was 
washed sequentially with HI buffer containing 50 mM KCl and 100 mM KCl. Finally, the 
column was eluted with a gradient of HI buffer containing from 200-400 mM KCl. RPA 
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elutes at ~300 mM KCl. 
 
2.3 Preparation of DNA substrate 
2.3.1 Preparation of double-stranded DNA and single-stranded DNA  
2.3.1.1 Large scale isolation of phage double-stranded DNA (dsDNA) 
    f1MR1 and f1MR3 phages were obtained from the laboratory of Paul Modrich 
(Duke University). The M13MP18-UKY1 and M13MP18-UKY2 phage were constructed 
in our laboratory.  
    50 ml O/N cultured XL1-Blue cells (selected with tetracycline, 2µg/ml) were 
inoculated into 3 L of 2×-YT medium pre-warmed to 37 °C. The culture was shaken at 37 
°C at 220 rpm using an orbital shaker until the OD595 reached 0.3 (Total cells at this OD 
were approximately 1.5×1012). The phages (about 1.5×1013) were added and the culture 
was continuously shaken for an additional 7 hours at 37 °C at 220rpm. To harvest the 
DNA, the cultures were chilled on ice for 20 min, and then centrifuged for 30 min at 
4500 rpm. The supernatant was kept for preparation of single-stranded DNA (ssDNA). 
The cell pellet was suspended in 60 ml of ice-cold solution I (25 mM Tris-HCl (pH8.0), 
10 mM EDTA, 0.9% glucose (w/v) and 5 mg/ml lysozyme). The cell suspension was 
incubated at RT for 10 min and then on ice for 10 min. 120 ml of freshly prepared 
solution II (0.2 N NaOH and 1% SDS) was added while stirring gently in a single 
direction with a 10 ml plastic pipette. The solution was then incubated on ice for 10 min. 
90 ml of solution III (mixture of 60 ml 5 M potassium acetate, 11.5 ml glacial (17.4 M) 
acetic acid and 28.5 ml ddH2O) was added to the lysed cell mixture while stirring as 
described in the previous step. After being incubated on ice for 10 min, the solution was 
centrifuged for 30 min at 13,000 g at 4°C. 
    The supernatant was filtered through 4 layers of cheesecloth. 0.6 vol of Iso-propanol 
was then added to precipitate DNA at room temperature (RT) for 30 min. DNA was 
collected by centrifugation for 30 min at 16000 g at 4°C. The DNA pellet was washed 
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with 70% ice-cold ethanol, and dried in air for 15-30 min. The DNA was suspended in 19 
ml TE solution (10 mM Tris-HCl pH 8.0, 1 mM EDTA), and the solution was weighed. 
Supercoiled DNA was isolated by CsCl/EtBr (1.05 g/g CsCl, 50 µl/g EtBr) equilibrium 
centrifugation at 45,000 rpm at 25°C for 18 hr using Beckman NVT65 rotor [112]. The 
band of supercoiled dsDNA was removed from the centrifuge tube using a syringe with 
an 18 gauge needle. EtBr was removed from DNA by water-saturated n-butanol 
extraction (4-6 times). The aqueous solution containing the supercoiled DNA was the 
dialyzed using TE buffer (pH 8.0). The concentration and purity of DNA was determined 
by measuring absorption at 260 and 280 nm using a UV-visible spectrophotometer [112].   
 
2.3.1.2 Large scale isolation of phage single-stranded DNA (ssDNA) 
    After adding NaCl (36 g/l) and PEG-8000 (50 g/l) into the culture supernatant, the 
solution was stirred at RT for 45 min, and centrifuged for 30 min at 4,500 rpm at 4°C. 
The pellet was suspended in 23 ml 10 mM Tris-HCl pH 8.0, incubated for 2 hours at 
37°C at 220 rpm, and centrifuged for 10 min at 14,500 g at 4°C. The supernatant was 
weighed. Phage particles were concentrated by CsCl (0.4342 g/g) equilibrium 
centrifugation as described above (2.3.1.1). The band of phage particles was removed 
from the centrifuge tube using a syringe with an 18 gauge needle, and dialyzed using TE 
buffer (pH 8.0). ssDNA was extracted from phage particles using TE (pH7.6)-balanced 
phenol (55°C, 4 times), and ethyl-ether (2 times). Centrifugation of the extraction was 
performed at 25 °C for 5 min at 12,000 g. After the ethyl-ether phase was evaporated, the 
solution was dialyzed using TE buffer (pH 8.0). The concentration and purity of DNA 
was measured by ultraviolet absorption at 260 and 280 nm [113]. 
 
2.3.2 Preparation of circular mismatch substrate 
    The substrate was prepared by annealing linear dsDNA with circular single-stranded 
DNA containing a one base difference to yield a circular dsDNA heteroduplex [114]; the 
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product contained a base mismatch and a nick/or gap at either 3’ or 5’ to the mismatch. 
The 5’-nicked mismatch substrate was constructed by using the dsDNA and ssDNA 
purified from f1MR1 and f1MR3. The 3’-nicked mismatch substrate was constructed by 
using the dsDNA and ssDNA purified from M13MP18-UKY1 and M13MP18-UKY2. 
DNA and an appropriate restriction enzyme to linearize circular dsDNA are listed in 
Table 2.1.  
 
 
 
 
 
 
 
 
   During annealing, the molar ratio of linear dsDNA and ssDNA is 1:4. dsDNA was 
denatured in a 30-ml solution of 50 mM Tris-HCl (pH 7.6), 100 mM NaCl, 1 mM EDTA, 
and 0.3 N NaOH (at RT for 5 min). The mixture was neutralized by adding 3.0 ml of 2.9 
N acetic acid, and adjusted with 1.35 ml of 3.0 M KCl and 3.7 ml 1.0 M K-Pi (pH 7.4 at 
100 mM). The C strand of linear dsDNA was annealed to circular ssDNA (V strand) by 
incubating the mixture at 65°C for 30 min, and gradually cooling to 37°C in a water bath 
(about 5 hours). After being incubated at 37°C for 30 min, the solution was stored on ice. 
The efficiency of annealing was determined by analysis of samples using 0.8% agarose 
gel electrophoresis.  
    Nicked circular dsDNA was separated from ssDNA and linear dsDNA through 
multiple steps of chromatography. First, Hydroxylapatite resin (BioRad, 1-1.2 g/mg of 
total DNA) was pre-equilibrated in 30 mM K-Pi (pH 6.9, 3 times). A column with a 
diameter of 2.5 cm was poured and washed with 2 volumes of 30 mM K-Pi (pH 6.9) at a 
Table 2.1. DNA used in mismatch substrate preparation
Substrate dsDNAssDNA Enzyme cutting dsDNA
5’ G/T nick 
3’ G/T nick 
5’ G/T gap 
5’ A/C gap 
3’ G/T gap 
3’ A/C gap 
f1MR1 
M13MP18-UKY2
f1MR1 
f1MR3 
M13MP18-UKY2
M13MP18-UKY1
f1MR3 
M13MP18-UKY1
f1MR3 
f1MR1 
M13MP18-UKY1
M13MP18-UKY2
Sau96I 
PstI 
Sau96I + DrdI
Sau96I+ DrdI
PstI + HincII 
PstI+ HincII 
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flow rate of 1-1.3 volume/ hour. The annealed substrate was loaded onto the column 
slowly. The resin bed was then washed with 6 volumes of 30 mM K-Pi (pH6.9), 160 mM 
K-Pi (pH6.9), and 420 mM K-Pi (pH6.9) respectively, and 1.0 ml fractions were collected 
with a fraction collector (Pharmacia). dsDNA was eluted by 420 mM K-Pi. Samples of 
the fractions (3 µl) were mixed with 7 µl of EtBr (1 µg/ml) on plastic wrap to visualize 
the peak of DNA, using a UV transilluminator. Next, appropriate fractions were pooled, 
and the purified dsDNA was concentrated 3-4 fold by n-butanol and dialyzed in TE 
(pH7.6) at 4°C. The concentration of dsDNA was measured by UV absorbance at 260nm. 
    Contaminating linear homoduplex dsDNA in the substrate preparation (pre-ExoV) 
was removed by digesting the preparation with bacterial exonuclease V. Digestion was 
performed in 66.7 mM Glycine, 5 mM MgCl2, 8.3 mM β- ME, and 0.5 mM ATP, and the 
final concentration for ExoV was 0.2 U/µg DNA. The solution was incubated at 37°C for 
60 min (post-ExoV). The efficacy of this step was performed by running pre-ExoV and 
post-ExoV DNA samples on a 1% agarose gel. A disappearing, fast migrating linear band 
indicated the removal of linear dsDNA from the preparation. The reaction solution was 
then extracted once with phenol and concentrated to 0.5 ml using n-butanol. 
    Free nucleotides from the ExoV digestion were separated from the circular DNA 
substrate (6.4 kb) using Sephacryl S300 (Pharmacia) column chromatography. 
TES-equilibrated (10 mM Tris-HCl (pH 7.6), 1 mM EDTA, and 0.3 mM NaCl) beads 
were poured into a glass column (45 cm × 1.2 cm). The resin bed was washed using 3 
volumes of TES. The concentrated ExoV digested DNA (about 0.5 ml) was loaded onto 
the column. After all the preparation entered the bed, TES buffer was added to the top of 
resin bed. The flow rate through the S300 column was 12 ml/hr. Once DNA was loaded 
onto the column, 1.0 ml fractions were collected with a fraction collector (Pharmacia). 
Substrate would typically be present around the 12th fraction. The purity of the substrate 
in the fractions was checked using 1% agarose gel electrophoresis, and appropriate 
fractions were pooled and concentrated 8 fold using n-butanol. After being dialyzed in TE 
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(pH 7.6), the concentration of substrate was measured by UV absorbance at 260 nm. 
    Gap-containing substrates were constructed in a similar manner as that of the nicked 
substrate except that circular dsDNA was digested by two enzymes. The longer fragment 
(separated with S300 chromatography) was then hybridized with ssDNA and purified as 
previously described. The substrates are shown in Figure 2.1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.3.3 Preparation of circular homoduplex substrate  
Nick-containing substrate: Sau96I-digested f1MR1 dsDNA was annealed with 
f1MR1 ssDNA. 35-nt gap-containing substrate: DrdI and Sau96I-digested f1MR1 
dsDNA fragments were separated with S300 chromatography. The longer fragments of 
linear dsDNA were denatured and annealed with f1MR1 ssDNA. 171-nt gap-containing 
substrate: DrdI and NheI-digested f1MR1 dsDNA was purified with S300 
chromatography. The longer fragments of linear dsDNA were denatured and annealed 
Figure 2.2 The structure of 
nicked, 35-nt gapped, and 171-nt 
gapped homoduplex. The black 
bars are the positions of probe 
binding: the left one is V5216 and 
the right one is V5932.  
Figure 2.1 The structure of 5’ and 3’ nicked or gapped mismatch substrates. (Right) 
6.4 kb 5’ mismatch substrates; black bar is the position of probe V5216. (Left) 7.1 kb 3’ 
mismatch substrates, black bar is the position of probe V6447. 
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with f1MR1 ssDNA. After annealing, substrates were purified essentially as described 
previously (2.3.2). The substrates are shown in Figure 2.2. 
 
2.3.4 Preparation of biotinylated linear substrate (5’ G/T as an example) 
    Circular substrates (both 3’ and 5’ nick or gap) were prepared as described above. 
They were then digested with BspHI to yield 5’CATG-containing sticky ends. 
Biotinylation of these ends was performed essentially as described The steps for 
biotinylation of 5’ G/T substrates were shown in Figure 2.3 [115]. Typically, a 300-µl 
reaction mixture included 0.3 µM DNA substrate, 3.0 µM dCTP, 3.0 µM Biotin-dATP, 
100 U Klenow DNA polymerase, 10 mM Tris-HCl (pH 7.5 at 25ºC), 10 mM MgCl2, and 
7.5 mM DTT. After incubation at 15°C for 2 hours, the biotinylated substrate was 
recovered by phenol extraction, ethanol precipitation.  
 
 
 
 
 
 
 
 
 
2.4 DNA MMR assay 
2.4.1 DNA MMR assay with circular substrate 
    The MMR assay was performed as described previously [106] in a 15-µl reaction 
mixture containing 23 fmol of heteroduplex DNA, 50 µg of nuclear extract proteins, 10 
mM Tris-HCl (pH 7.6), 5 mM MgCl2, 100 mM KCl, 1.5 mM ATP, and 0.1 mM dNTPs. 
After incubation at 37°C for indicated times, DNA samples were recovered by phenol 
Figure 2.3 The steps for biotinylation of 5’ G/T substrate. 
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extraction and ethanol precipitation, and digested with the restriction enzymes (see table 
2.2). The products were analyzed by 1% agarose gel. Two of the three digestion bands (at 
3.1 kb and 3.3 kb for 5’ substrate, 3.0 kb and 4.1 kb for 3’ substrate) corresponded to the 
repair products.  
 
 
 
 
 
 
 
 
2.4.2 MMR assay with 5’ nicked biotinylated linear G/T substrate 
    For MMR assays with biotinylated linear substrates, 138 fmol of biotinylated DNA 
substrate was immobilized on 15 µl of packed streptavidin-sepharose (4ºC, 2h rotation in 
PBS buffer). An MMR assay was performed in a 45-µl reaction mixture, containing 250 
µg of nuclear extract, 10 mM Tris-HCl (pH 7.6), 5 mM MgCl2, 100 mM KCl, 1.5 mM 
ATP, and 0.1 mM dNTPs. The assay was initiated by adding the reaction mixture to the 
streptavidin-conjugated DNA, and was incubated at 37°C on a rotating rack. The reaction 
was terminated by adding 60 µl of proteinase K solution (10 mM Tris-HCl pH 8.0, 1 mM 
EDTA, and 9 mg/ml proteinase K, Sigma) to digest proteins still bound to DNA and to 
release DNA from the beads into solution. After 30 min of incubation at 37 ºC, the 
aqueous phase was extracted with phenol. After ethanol precipitation, the DNA samples 
were digested with the restriction enzymes BspDI and HindIII to score the amount of 
repair. The reaction products were analyzed by 1% agarose gel electrophoresis. 
Generation of bands at 3.1 kb and 2.1 kb are indicative of repair. 
 
Table 2.2. Restriction Enzyme for DNA repair products assay
5’ G/T nick 
3’ G/T nick 
5’ G/T gap 
5’ A/C gap 
3’ G/T gap 
3’ A/C gap 
BspDI + HindIII
BseRI + NsiI 
BspDI + HindIII
BspDI + XhoI 
BseRI + NsiI 
BseRI + XhoI 
3.1kb, 3.3kb 
3.0kb, 4.1kb 
3.1kb, 3.3kb 
3.1kb, 3.3kb 
3.0kb, 4.1kb 
3.0kb, 4.1kb 
Substrate Enzyme Products 
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2.5 MMR excision assay 
2.5.1 MMR excision assay by detecting the loss of restriction enzyme site 
    MMR excision assays were performed as described previously [106] in a 15-µl 
reaction mixture containing 23 fmol of heteroduplex DNA, 50 µg of nuclear extract 
proteins, 20 mM Tris-HCl (pH 7.6), 5 mM MgCl2, 110 mM KCl, 1.5 mM ATP (without 
dNTPs in the reaction). After incubation at 37°C for the indicated times, reactions were 
terminated via proteinase K digestion and DNA samples were recovered by phenol 
extraction and ethanol precipitation. To score the amount of excision beyond the 
mismatch, 3’-substrates were digested with the restriction enzymes BseRI and HindIII; 
while 5’-substrates were digested with BspDI and NheI. The products were separated on 
1% agarose gels and DNA bands were visualized by UV illumination in the presence of 
EtBr. For the 5’ substrate, the band located at 6.4 kb corresponds to excision products 
(loss of NheI digestion site). For the 3’ substrate, the band located at 7.1 kb corresponds 
to excision products (loss of HindIII digestion site).  
 
2.5.2 Detection of MMR excision by Southern blot 
    DNA excision intermediates were visualized using the Southern blotting technique, 
performed essentially as described [116]. MMR reactions were carried out as described 
above but without dNTPs, and 46 fmol samples of DNA were recovered by phenol 
extraction and ethanol precipitation. For 5’-substrates, DNA was digested with SspI. 
After digestion, the DNA was denatured and separated on 6% PAGE -8M Urea gel in 1× 
TBE buffer (89 mM Tris, 89 mM boric acid and 2 mM EDTA), then electro-transferred 
onto a membrane (Hybond-NX) in 0.5×TBE using a BioRad electroblotting apparatus. 
Membranes were exposed to a 32Pi-labeled (V5216) oligonucleotide probe that is 
complementary to the sequence on the nicked strand near the SspI restriction site (as 
indicated on Figure 2.1). For 3’-substrates, DNA was digested with SspI and DraIII; 
membranes were prepared as before, and were exposed to a 32Pi-labeled (V6447) 
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oligonucleotide probe, that is complementary to the sequence on the nicked strand near 
the SspI restriction site. Reaction products were visualized by autoradiography. The 
sequences of probes were listed in table 2.3. 
 
 
 
 
 
 
 
 
2.5.3 Detection of mismatch excision of the biotinylated G/T using Southern blot 
    138 fmol of biotinylated 5’ G/T DNA substrate was immobilized onto 15 µl of 
packed streptavidin-sepharose (4ºC, 2 hr rotation in PBS buffer). The excision assay was 
performed in a 45-µl reaction mixture, containing 250 µg of nuclear extract, 10 mM 
Tris-HCl (pH 7.6), 5 mM MgCl2, 100 mM KCl, and 1.5 mM ATP. The assay was initiated 
by adding the reaction mixture to the streptavidin-conjugated DNA, and was incubated at 
37°C on a rotating rack. The reaction was terminated by the addition of 60 µl of 
proteinase K solution (10 mM Tris-HCl pH 8.0, 1 mM EDTA, and 9 mg/ml proteinase K, 
Sigma) to digest proteins still bound to DNA and to release DNA from the beads into 
solution. The rest of steps are same as described in 2.5.2.  
 
2.6 DNA resynthesis analysis  
2.6.1 Assay for the recovery of a restriction enzyme site  
    Reactions were performed in a 30-µl reaction mixture, containing 150 µg of nuclear 
extract proteins, 10 mM Tris-HCl (pH 7.6), 5 mM MgCl2, 100 mM KCl, 1.5 mM ATP, 
0.80 mM dNTPs, and 46 fmol of the 171-nt gapped DNA substrate at 37°C for the 
Table 2.3. Oligonucleotides used for Southern blot assay
Substrate Sequence of Probe
3’substrate      V6447    5’-CTCAAACTGGCAGATGCACGG-3’ 
5’substrate      V5216    5’-ATTGTTCTGGATATTACCA-3’   
171-nt gap      V5932    5’-AAAATTTAACGCGAATTTT-3’  
Probe Name
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indicated times. DNA was recovered by proteinase K digestion, phenol extraction and 
ethanol precipitation, and digested with HindIII and BspDI. The products were separated 
on 1% agarose gels. The appearance of the 3.1 kb and 3.3 kb bands indicated synthesis 
products, while the 6.4 kb band indicated the presence of the gap substrate. The density 
of the bands was quantitated by NIH Image 1.63f. Percentage of DNA synthesis = 100 × 
(D3.1 + D3.3)/(D3.1 + D3.3 + D6.4). 
 
2.6.2. Visualizing the synthesis products using Southern blot 
    Reactions and DNA recovery were performed as described in 2.6.1. The recovered 
DNA was digested with SspI, separated by 6% PAGE (8M Urea) denaturing gel, and 
electro-transferred onto a membrane. The membrane was blotted with 32Pi-labeled 
oligonucleotide probes (V5932) complementary to sequences that flank the SspI 
restriction site on the nicked strand (Figure 2.2). Reaction products were visualized by 
autoradiography. 
 
2.7 Protein pull-down assay with biotinylated linear dsDNA  
    500 fmol (or indicated) of biotinylated DNA substrate was pre-attached to 15 µl of 
packed streptavidin-sepharose. An assay was performed in a 45-µl reaction mixture, 
containing 250 µg of nuclear extract or the indicated amount of pure proteins (RPA), 10 
mM Tris-HCl (pH 7.6), 5 mM MgCl2, 100 mM KCl, 1.5 mM ATP, and 0.10 mM dNTPs. 
The assay was initiated by adding the reaction mixture to the streptavidin-conjugated 
DNA, and was incubated at 37°C on a rotating rack. Proteins binding to DNA were 
determined using Western blot in the following manner: at indicated time points, 800 µl 
of low salt washing buffer (50mM Tris-HCl pH 7.4, 150 mM NaCl, 1% NP-40, 0.5% 
Triton X-100, with proteinase inhibitors) was added into reaction. After all time points 
finished, the beads were spun down (800 rpm, 1 min), then washed with low salt and high 
salt washing buffer (same as low salt buffer but with 500 mM NaCl). After adding 
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1×SDS loading buffer into complexes and boiling, protein samples were separated using 
10% SDS-PAGE gels. The proteins were transferred onto nitrocellulose, and visualized 
by ECL.  
 
2.8 DNA binding assay of RPA  
2.8.1 Competition among RPA2D, RPA2A, and RPA2WT for ssDNA binding (1) 
RPA2D (4.8 pmol), or RPA2A (3.2 pmol), or RPA2WT (3.2 pmol) was incubated with 
biotin-ssDNA (380 nt, 85fmol/reaction) pre-attached to streptavidin-sepharose at 37ºC for 
10 min in a 30-µl reaction mixture containing 10 mM Tris-HCl (pH 7.6), 5 mM MgCl2, 
100 mM KCl, and 8 µg/µl BSA. After the reaction, the beads were washed with low salt 
washing buffer and high salt washing buffer to get RPA2D:ssDNA complex, 
RPA2A:ssDNA complex, or RPA2WT:ssDNA complex. Then adding 0, 1.6, 3.2, 6.4 pmol 
RPA2WT or RPA2A into RPA2D:ssDNA complex, or adding 0, 1.6, 3.2, 6.4 pmol RPA2D 
into RPA2A:ssDNA complex, or adding 0, 1.6, 3.2, 6.4 pmol RPA2D into RPA2WT:ssDNA 
complex, and the mixture (also containing 10 mM Tris-HCl (pH 7.6), 5 mM MgCl2, 100 
mM KCl, and 8 µg/µl BSA) was incubated at 37ºC for 10 min. The beads were washed 
with low salt washing buffer and high salt washing buffer, RPA pulled down by ssDNA 
was detected using Western blot with RPA2 monoclonal antibody.  
 
2.8.2 Competition among RPA2D, RPA2A, and RPA2WT for ssDNA binding (2) 
Mixture of RPA2D (1.6 pmol) and RPA2A (1.6 pmol), or RPA2D (1.6 pmol) and 
RPA2WT (1.6 pmol) were incubated with increasing amounts of biotin-ssDNA (380 nt, 0, 
42, 85, 170 fmol) immobilized on streptavidin-sepharose at 37ºC for 10 min. The 30-µl 
reaction mixture also contained 10 mM Tris-HCl (pH 7.6), 5 mM MgCl2, 100 mM KCl, 
and 8 µg/µl BSA.  After the reaction was completed, the beads were washed with low 
salt washing buffer and high salt washing buffer, RPA pulled down by ssDNA was 
detected using Western blot with RPA2 monoclonal antibody.  
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2.8.3 32Pi-RPA2WT releasing test 
2.8.3.1 Formation of 32Pi-RPA:biotin-G/T:streptavidin-sepharose complex  
    Before reactions began, 500 fmol of biotinylated G/T heteroduplex was pre-attached 
to 15 µl of packed streptavidin-sepharose (4ºC, 2h rotation in PBS buffer). The reactions 
were performed in a 30-µl reaction mixture, containing 16.6 pmol of RPA2WT, 150ng of 
purified DNA-PK, 10 mM Tris-HCl (pH 7.6), 5 mM MgCl2, 100 mM KCl, and 10 µCi 
γ-32Pi-ATP, at 37°C on a rotating rack for 20 min. Free γ-32Pi-ATP and DNA-unbound 
proteins were washed away by low salt and high salt washing buffer.  
 
2.8.3.2 Release of 32Pi-RPA from 32Pi-RPA:biotin-G/T complex 
    The complexes were incubated with increasing amount of either RPA2WT or RPA2D 
in the presence of 10 mM Tris-HCl (pH 7.6), 5 mM MgCl2, 100 mM KCl, 1.5 mM ATP, 
and 0.1 mM dNTPs at 37ºC on rotating rack for 10 min. After reaction, the beads were 
collected by centrifugation (800 rpm, 1min), and washed three times with low salt buffer. 
Radioactivity of supernatant (s) and beads (b) was measured by scintillation counting. 
Percentage of RPA binding was calculated using the formula: 100×b/(s+b).  
 
2.8.4 Stop-flow kinetic assay of RPA 
2.8.4.1 kon value of RPA  
Stop-flow kinetic traces were obtained using a KinTek Stop-flow Instrument [117]. 
Equal volumes (80 µl) of RPA (15 nM) and ssDNA (21-mer MU5T, 47, 78, 130, 216, 360, 
600, and 1000 nM. 5’-GCTGAAGCAGAAGGCTTCATT-3’) in buffer containing 20 
mM Tris-HCl (pH 7.6), 100 mM KCl, and 5 mM MgCl2 from separate syringes were 
rapidly mixed (8ml/sec) at 39.4 °C. Fluorescence was measured following excitation at 
280 nm using a 330-nm long-pass cut-on filter (Corion 51950). Constant RPA (7.5 nM 
final concentration) and varying ssDNA concentrations (23.5, 39, 65, 108, 180, 300, and 
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500 nM) were used to achieve pseudo-first order kinetics. The traces depicted for each 
concentration of ssDNA represents the average of 12-20 individual injections. The kinetic 
data were fit using KinTek software to calculate the observed rate, kobs. The data was fit to 
a single-exponential decay: Y=A1*e(-k1t) + C1 (kobs = k1). Assuming a simple mechanism of 
ssDNA binding, RPA + ssDNA  ↔  RPA·ssDNA, then in the condition where 
[ssDNA]>>[RPA], kobs = kon [ssDNA] + koff, where the slope is the bimolecular 
association rate, kon.  
 
2.8.4.2 koff value of RPA  
Stop-flow kinetic traces were obtained using a KinTek Stop-flow Instrument [117]. 
Equal volumes (80 µl) of pre-equilibrated RPA:ssDNA complex (H-U5T, 
hexachloroflurescein labeled-21-mer) (20nM:20nM) and DNA (21-mer MU5T, 600nM) 
in buffer containing 20 mM Tris-HCl (pH 7.6), 100 mM KCl, and 5 mM MgCl2 from 
separate syringes were rapidly mixed (8ml/sec) at 39.4°C. Fluorescence was measured 
following excitation at 535 nm using a 555-nm long-pass cut-on filter (Corion LG-555). 
The traces depicted represents the average of 8~12 individual shots. The kinetic data were 
fit using KinTek software to calculate the observed rate, kobs. The data was fit to a 
single-exponential decay: Y=A1*e(-k1t) + C1 (kobs = k1). Assuming a simple mechanism of 
ssDNA binding, RPA·*ssDNA → *ssDNA + RPA, and RPA is sequestered by ssDNA, 
then the reaction is considered as irreversible, so, kobs= koff. KD values were calculated 
using the following equation: KD =koff/kon. 
 
 
2.9 Application of the inhibitors 
2.9.1 Wortmannin  
    Wortmannin was dissolved in DMSO to 1 mM and aliquot at 5 µl/tube. Before using, 
75 µl of 100 mM KCl was added.  For the control, 75 µl of 100 mM KCl was added into 
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5 µl DMSO. Final concentration for Wortmannin is 4.1 µM [102, 118].  
 
2.9.2 Aphidicolin  
    Aphidicolin was dissolved in DMSO to 10 mM and aliquot at 10 µl/tube. Before 
using, 90ul 100 mM KCl was added. Working concentration for Aphidicolin is 66.6 µM 
[106, 119, 120] 
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CHAPTER 3. Sequential Binding of Human MMR Proteins to a Heteroduplex DNA 
 
INTRODUCTION 
    DNA mismatch repair (MMR) plays an important role in maintaining genomic 
stability in almost all living organisms [12-14]. The function of MMR is to remove bases 
that are incorrectly paired with template bases during the processes of DNA replication 
and recombination [7]. The importance of the MMR system in maintaining genomic 
stability in humans is underscored by the fact that defects in this system are thought to be 
the pathological basis of hereditary non-polyposis colorectal cancer (HNPCC) and certain 
sporadic cancers [2, 6-8]. 
    Our understanding of the mechanism of MMR has been greatly advanced by the 
development of in vitro assays to study this system. The prototype of the in vitro cell-free 
MMR assay was created over twenty years ago by Modrich and co-workers, to study base 
mismatch correction by bacterial cells extracts [114], and variations of this assay are now 
used to study the mechanism of MMR in human cell nuclear extracts. Typically, a circular 
DNA duplex containing an “error” (either a single mismatch or several unpaired bases) 
and a nick that is located either 5’ or 3’ from the error is utilized (Figure 2.1). Using this 
assay and other techniques, it is known that MMR has three general steps in all organisms 
studied to date. First, the error is recognized by protein initiation factors. Next, the error 
in the nicked strand is excised through the action of exonucleases and other accessory 
proteins to yield single stranded DNA in a mismatch-provoked way, and, finally, the 
single stranded DNA is replicated by a DNA polymerase to complete the repair. 
Utilization of the in vitro assay has allowed the identification of proteins required for 
initiation in human cells (i.e., MutSα, MutSβ, and MutLα) and excision (Exo1) of human 
MMR [41, 42, 44, 49]. In addition, recent work has shown that DNA polymerase δ [50], 
proliferating cell nuclear antigen (PCNA) [56, 58, 121], replication factor C [54] and 
replication protein A (RPA) [51, 52] participate in DNA mismatch repair, although the 
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specific function of these proteins in processing of heteroduplex DNA is not clear.  
In vitro MMR assays show the different MMR proteins perform their function at 
different steps of MMR. Therefore, we hypothesize that different MMR proteins interact 
with the heteroduplex DNA at different steps of MMR. Although assay using the circular 
mismatch substrate can be used to identify the proteins required for the MMR pathway 
[122] and to study the dynamic processing of heteroduplex DNA by the MMR system, 
they cannot show the dynamic relationship between the binding of MMR proteins to 
heteroduplex and the processing of heteroduplex by MMR system. 
In this study, the circular mismatch substrate was modified to produce a biotinylated 
linear mismatch substrate. This substrate not only can be pulled down by 
streptavidin-sepharose, but also can be repaired by DNA MMR system in huame cells. 
Using this resin-bound linear heteroduplex DNA substrate to perform time courses of 
mismatch repair, mismatch excision, and protein binding, the results show that the RPA, 
MSH2, MLH1, PCNA, and DNA polymerase δ bind to heteroduplex in a sequential 
manner, consistent with current models of how these proteins act in the MMR pathway. 
The data also demonstrate that a dramatic increase of PCNA binding to heteroduplex 
DNA is associated with the appearance and increase of excision products, which suggests 
that PCNA performs a role in mismatch excision. Interestingly, the pull-down assay 
shows that RPA2 is phosphorylated during the incubation at 37°C, and that RPA2 
phosphorylation is associated with the binding of DNA polymerase δ to heteroduplex 
DNA and the appearance of repair products. These results indicate the role of RPA 
phosphorylation in DNA MMR.  
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RESULTS  
Repair of linear nicked heteroduplex is MMR system dependent 
    Streptavidin has a very high affinity for biotin, and for this reason, resins with 
covalently-linked streptavidin are widely used as matrices for affinity chromatography 
[115]. Labeling a heteroduplex substrate with biotin would allow isolating proteins 
involved in MMR step by step. To generate a biotinylated mismatch-containing DNA 
substrate (Figure 3.1A), a 6.4 kb 5’ nicked circular G/T substrate was digested with 
BspHI to yield 5’-CATG-3’ ends. Biotin-dATP was incorporated into the substrate as 
described in Materials and Methods (Figure 2.3). To test the efficiency of biotinylation, 
the linear dsDNA was incubated with an excess of streptavidin-sepharose in the presence 
or absence of biotin at room temperature for 2 hr. Beads were collected by centrifugation, 
and the amount of DNA in the supernatant was determined via agarose-gel 
electrophoresis. As shown in Figure 3.1 B, if using streptavidin-sepharose to deplete 
biotin-labeled dsDNA from solution, less than 30% dsDNA remains in the supernatant 
(lane 1 vs. lane 2). However, when free biotin is added, streptavidin-sepharose binds the 
free biotin and biotin-labeled dsDNA remains in solution, and more than 95% dsDNA is 
observed in the supernant (lane 1 vs. lane 3). Additionally, incubating unlabeled linear 
DNA with streptavidin-sepharose causes less than 1% DNA to be associated with the 
beads (data not shown). These data indicate that more than 70% of linear dsDNA is 
biotinylated, and the biotinylated linear dsDNA can be pulled down by 
streptavidin-sepharose. 
    Traditionally, a circular DNA substrate has been used the in vitro MMR assay. 
Whether the repair of the linear heteroduplex is MMR system dependent is not known. To 
test this, the biotinylated linear heteroduplex containing a strand break 5’ to the mismatch 
was incubated with MMR-proficient or MMR-deficient cell nuclear extract, and repair 
was scored by the recovery of HindIII digestion site as described for the circular 
heteroduplex. If the mismatched base pair is repaired, the homoduplex dsDNA can be 
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digested by HindIII to yield two fragments. As shown in Figure 3.1 C, linear 
heteroduplex can be repaired by an MMR-competent nuclear extract (HeLa, Figure 3.1 C, 
lane 1), but not by the MSH2-deficient N6 nuclear extract (Figure 3.1 C, lane 2) or the 
MLH1-deficient H6 nuclear extract (Figure 3.1 C, lane 3). Addition of purified MutSα 
into the N6 reaction (Figure 3.1 C, lane 4) or purified MutLα into the H6 reaction (Figure 
3.1 C, lane 5) allowed the linear heteroduplex to be repaired. These data suggest that the 
repair of linear nicked heteroduplex DNA is DNA MMR system dependent.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1 Biotinylated linear G/T 5’-nicked DNA can be repaired by MMR system. (A) Structure 
of the linear biotinylated MMR substrate (B-Sub). The substrate contains a G/T mismatch, and a nick 
that is 127 base pairs 5’ to the mismatch. (B) B-Sub can be pulled down by streptavidin-sepharose
(SAV-seph). B-Sub was incubated with SAV-seph in the presence and absence of free biotin at 4 ºC for 
2 hrs. Beads were spun down, and the amount of DNA in the supernatant was determined via 
agarose-gel electrophoresis. (C) Linear nicked heteroduplex dsDNA is repaired by the human MMR 
system. The MMR reactions were performed in a 15-ul reaction using linear 5’nicked G/T. After MMR 
reaction, recovered DNA was digested with HindIII. Repair products (4.3kb and 3.1kb) and unprepared 
DNA were separated via agarose-gel electrophoresis. Lane 1: HeLa nuclear extract; lane 2: N6 
(MSH2-/-) nuclear extract; lane 3: H6 (MLH1-/-) nuclear extract; lane 4: N6 nuclear extract + MutSα; 
Lane 5: H6 nuclear extract + MutLα. 
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Comparison of the repair and excision of the resin-bound substrate to a circular 
substrate  
    To determine how heteroduplex is processed by MMR system in human cells, a time 
course of mismatch repair and excision was performed using a circular 5’ nicked G/T 
substrate. In mismatch repair assay, the circular 5’ nicked G/T substrate was incubated 
with HeLa nuclear extract at 37°C for indicated time, and a unique HindIII restriction site 
will be restored if the mismatch is repaired. Therefore, repair products can be digested by 
both HindIII and BspDI to yield two fragments, while unrepaired DNA remains resistant 
to HindIII and is digested by BspDI to yield a single longer fragment. The time course of 
mismatch repair shows that repair products appear after 2 min of reaction and increase 
dramatically after 4 min of reaction (Figure 3.2 A). In mismatch excision assay, the 
reactions were performed similarly as in repair assay but in the absence of dNTPs. 
Therefore, the nicked strand will be excised from nick toward and beyond mismatch site, 
but no gap filling occurs. After reaction, recovered DNA was digested by SspI. The 
excision intermediates are detected using Southern blot. As shown in Figure 3.2 B, the 
nicked strand is shorter and shorter with the increase of reaction time. The excision 
products that pass through mismatch site are detectable after 1 min of the reaction (Figure 
3.2 B). A direct comparison of these time courses thus confirms that mismatch excision is 
followed by DNA resynthesis. 
To determine if a resin-bound linear heteroduplex is repaired and excised with 
kinetics similar to that of the circular substrate, the similar experiment to that described 
above but using the resin-bound linear substrate was performed. In this substrate, the 
repaired DNA can be cut into four fragments (two of them indicate repair products) by 
HindIII and BspDI, and unrepaired DNA can be cut by BspDI but not HindIII to yield 
two fragments. As shown in Figure 3.3 A, MMR can occur on a resin-bound linear 
substrate, and the repair products is observed after 6 min of reaction, later than seen for  
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Figure 3.3 Time courses of DNA excision and repair using the bead-bound linear heteroduplex. (A) 
Time course of MMR products. 138 fmol biotinylated linear 5’ nicked G/T immobilized on
streptavidin-sepharose was added to HeLa nuclear extract (250 µg). After reaction, recovered DNA was 
digested with BspDI and HindIII, and separated on 1% agarose gel. (B) Time course of mismatch 
excision. Reactions were performed as in A in the absence of dNTPs to block DNA resynthesis. 
Recovered DNA was digested with SspI. Excision intermediates were detected using Southern blot with 
32Pi-V5216. Note that excision begins earlier than when repair product is observed.  
Figure 3.2 Time courses of DNA excision and repair using a circular substrate (A) Time course of 
MMR product formation. After reaction, recovered DNA was digested with BspDI and HindIII, and 
separated on 1% agarose gel. (B) Time course of mismatch excision. Reactions were performed as in A in 
the absence of dNTPs to block DNA resynthesis and recovered DNA was digested with SspI. Excision 
intermediates were detected using Southern blot with 32Pi-V5216. Note that excision begins earlier than 
when repair product is observed.   
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the circular substrate (Figure 3.2 A). The excision patterns of the circular substrate and a 
resin-bound linear heteroduplex are similar (Figure 3.2 B vs. Figure 3.3 B), with 
mismatch excision intermediates passing through the mismatch site at about 2 min 
(Figures 3.2 B and 3.3 B). For the reactions occurring either on the surface of resin or in 
the solution, the results demonstrate a similar principle: that mismatch excision is 
followed by DNA resynthesis.  
 
Proteins that are required for MMR bind to DNA in a sequential manner 
    The time course of resin-bound 5’ nicked linear heteroduplex processing by MMR 
system in HeLa nuclear extract shows that mismatch excision begins before 2 min of 
reaction and gap filling can pass the mismatch site before 6 min of reaction. According to 
the function of MMR proteins in DNA MMR, MutSα and MutLα would be expexted to 
associate with heteroduplex before 2 min of reaction and DNA polymerase δ should 
associate with heteroduplex before 6 min of reaction. To determine whether this is the 
case, resin-bound 5’ nicked linear heteroduplex substrate was incubated with HeLa 
nuclear extract at 37ºC. At the indicated times, resin was pelleted and DNA-bound 
proteins were isolated and detected by Western blot using monoclonal antibodies to 
MSH2 (MSH2 is a subunit of MutSα), MLH1 (MLH1 is a subunit of MutLα), DNA 
polymerase δ (125 kD subunit) [6, 7], PCNA, RPA70 and RPA32. Time course of protein 
pull-down assay shows that MSH2 and MLH1 bind to the heteroduplex substrate as early 
as 30 seconds after initiation of the incubation, and that MSH2 binds slightly earlier than 
MLH1 (Figure 3.4 A). These data confirm that mismatch recognition by MutSα and 
MutLα is earlier than mismatch excision directly (compare Figure 3.3 B with Figure 3.4 
A). In addition, the levels of MSH2 and MLH1 pulled down by the substrate decreased 
after 20 min of incubation, which might suggest that they are dissociated from DNA after 
the mismatched nucleotide is removed (compare Figure 3.3 A with Figure 3.4 A).  
Modrich and co-workers have shown that DNA polymerase δ is required for repair 
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of a 5’ mismatch or 3’-dinucleotide loop [50]. The time course of protein pull-down assay 
shows that DNA polymerase δ is bound to the heteroduplex after 4 min of reaction 
(Figure 4 A), which is later than mismatch recognition and mismatch excision but earlier 
than the appearance of repair products (Figure 3.3 A). The data confirms that DNA 
polymerase δ performs its function during the DNA resynthesis step of MMR.    
In addition to its role as a cofactor of DNA polymerase δ, PCNA plays multiple roles 
in DNA metabolism. It has been shown that PCNA has roles in MMR at both the DNA 
resynthesis step [56] and prior to DNA resynthesis step [121]. The time course of protein 
pull-down assay shows that PCNA binds to the heteroduplex before mismatch excision, 
and that a dramatic increase of PCNA binding is associated with the appearance of 
excision products. This data suggest that PCNA plays a role in mismatch excision. How 
PCNA is involved in mismatch excision will be discussed in Chapter 4.  
It has been shown that RPA is required for MMR [51, 52, 59, 62]. A previous study 
from our laboratory demonstrated that RPA was required for DNA MMR at both the 
excision step and DNA resynthesis step [52]. Here, The time course of protein pull-down 
assay shows that RPA binds to nicked heteroduplex DNA as early as the MSH2 and 
MLH1 proteins do (compare Figure 3.3 B with Figure 3.4 A); RPA2 is phosphorylated 
during MMR, and phosphorylation of RPA2 correlates well with the binding of DNA 
polymerase δ and the appearance of repair product (compare Figure 3.3 A with Figure 3.4 
A). This data not only further support our previous observation that RPA is required for 
DNA MMR at both excision step and DNA resynthesis step but also suggest that 
phosphorylation of RPA2 may play a functional role in human MMR.  
 
Binding of RPA, PCNA and DNA polymerase δ to substrate is mismatch 
independent  
     For the proteins detected above, only MSH2 (MutSα/β) and MHL1 (MutLα) are 
specific for MMR [6, 7]. Other proteins are also required for DNA replication and other 
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DNA metabolism. To understand if these proteins bind to the substrate in a 
mismatch-independent manner, biotinylated linear 5’ nicked A/T was used in the  
pull-down assay as above. Western blot analysis shows that DNA polymerase δ, PCNA, 
RPA bind to the homoduplex and that RPA2 is phosphorylated during 37°C incubation 
(Figure 3.4 B); but MSH2 cannot be pulled down by linear 5’ nicked A/T, and a little 
amount of MHL1 is pulled down by this nicked homoduplex after 6 min incubation 
(Figure 3.4 B). Our observations and those made by other laboratories support the idea 
that DNA polymerase δ, PCNA, and RPA are definitely required for or involved in MMR 
although they are not specific for DNA MMR. 
     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
It is worth mentioning that RPA2 phosphorylation and DNA polymerase δ binding 
Figure 3.4 Specificity of known MMR factors for biotinylated linear substrates. Time course 
analysis of DNA MMR was performed using 500 fmol nicked G/T substrate (A) or 500 fmol nicked A/T
homoduplex (B). Both were pre-attached to streptavidin-sepharose, and incubated with HeLa nuclear 
extract (~250 µg protein) in a 45-uL mixture at 37ºC. At the indicated times, substrate was recovered, 
washed, and specifically bound proteins were eluted from the DNA using 1×SDS sample-loading buffer. 
Samples were run on PAGE-SDS gels, followed by Western blot analysis.   
MSH2 
MLH1
pol δ 
PCNA 
RPA1 
RPA2 
time (min)  0  0.5  1   2  4   6  10  20 
A 
0  0.5  1   2  4   6  10  20 
B
Pi-RPA2
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to DNA were also observed in the proteins pull-down using homoduplex (Figure 3.4 B). 
When nicked or gapped homoduplexes are incubated with HeLa nuclear extract, nick- or 
gap-directed homoduplex excision and DNA resynthesis occur [106, 123], which may be 
conducted by RPA and DNA polymerase δ. Thus, RPA phosphorylation seems to play an 
important role in repair DNA resynthesis.  
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DISCUSSION 
    In this chapter, resin-bound linear 5’ nicked heteroduplex DNA was used to examine 
mismatch excision, repair, and protein binding over time. The results demonstrate the 
sequential binding of MMR proteins to a 5’ nicked linear mismatch dsDNA and the 
sequential processing of this dsDNA by the MMR system in human cells. Based on these 
results, the time of MMR proteins binding to heteroduplex and heteroduplex processing 
follows the next sequence: MutSα and RPA binding → MutLα and PCNA binding, more 
MutSα and RPA binding → more MutLα, PCNA, MutSα and RPA binding, appearance 
of RPA2 phosphorylation → mismatch excision → increase of RPA2 phosphorylation, 
and DNA polymerase δ binding → appearance of repair products. Although it has been 
reported that Exo1 is involved in MMR [49, 59, 62, 76, 124], a good Exo1 antibody is not 
commercially available to test whether it is bound to the substrate.  
    A previous study from our laboratory shows that RPA is required for MMR at both 
the excision step and DNA resynthesis step. No repair products were observed if the 
MMR repair reaction is performed using RPA-depleted HeLa nuclear extract. This might 
be due to that the single-stranded template generated during excision is degraded by 
nucleases before repair DNA resynthesis, resulting in the loss of template for DNA 
resynthesis [52]. This hypothesis is supported by our observations that RPA binds to the 
nicked mismatch dsDNA as early as mismatch recognition. In addition, our observations 
here indicate that RPA and MutSα might recognize different portions of the nicked 
heteroduplex DNA: MutSα binds to the mismatched base pair and RPA binds to the nick. 
Interestingly, we find that RPA2 is phosphorylated during the MMR process, and the time 
of RPA2 phosphorylation is coincident with DNA polymerase δ binding (Figure 3.4 A). 
Although it has been reported that RPA2 phosphorylation is associated with cell cycle 
progression (S-phase and M-phase) [125] and  exposure of DNA to damaging agents 
such as UV or ionizing radiation [105, 126], nobody has shown that RPA2 is 
phosphorylated during MMR. Additionally, the function of RPA2 phosphorylation in 
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DNA metabolism is still unclear. The function of RPA2 phosphorylation in DNA MMR is 
discussed in Chapter 5. 
    As one of the important components of the MMR system in human cells, PCNA is 
required for both the DNA resynthesis step and a pre-resynthesis step [56, 121]. Here we 
find that a dramatic increase of PCNA binding to DNA is coincident with the apperance 
and increase of excision intermediates (compare Figure 3.3 B with Figure 3.4 A). 
    RPA, PCNA and DNA polymerase δ also bind to linear homoduplex DNA, 
suggesting that these proteins are involved in non-specific DNA synthesis, i.e., nick 
translation (5’→3’ excision) [127]. Actually, abundant nucleases exist in HeLa nuclear 
extract. As long as a nick or gap exists in dsDNA, mismatch independent 5’→3’excision 
occurs, although the process is weaker than mismatch stimulated 5’→3’excision [106, 
123]. Based on these observations, we can clearly put the proteins involved in DNA 
MMR into two groups: one group containing MutSα (MSH2) and MutLα (MLH1) is 
MMR specific; the other group including RPA, PCNA and DNA polymerase δ is also 
required for general DNA metabolism. Given that RPA, PCNA and DNA polymerase δ 
are major DNA replication factors, it is possible that DNA MMR in human cells is a 
DNA replication-coupled process [3]. 
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CHAPTER 4. Differential Requirement for PCNA in 5’ and 3’ Nick-Directed 
Mismatch Excision 
 
INTRODUCTION 
At the present time, the proteins MutSα, MutSβ, MutLα, Exo1, polymerase δ, 
PCNA, RPA and HMGB1 are known to be involved in human MMR [2, 6, 7, 41, 42, 44, 
49, 52-54, 73, 121], and completion of repair involves the concerted action of these and 
other unidentified proteins. Initiation of MMR is thought to occur through the binding of 
MutSα (MSH2:MSH6) to a mismatch, followed by the recruitment of MutLα to form a 
ternary complex. Removal of the mispaired base(s) occurs by strand excision. In this 
poorly understood process, a strand break located either 5’ or 3’ from the mismatch can 
serve as a starting point for the unwinding of the DNA duplex to allow an exonuclease to 
digest the strand containing the nick. Exonuclease 1 (Exo1), a 5’ →3’ exonuclease, has 
been identified to be involved in DNA mismatch repair [49, 76]. In addition, HMGB1 
plays an important role in stimulating the excision of either 5’ or 3’ nick-containing 
mismatch substrate [53]. Once the nicked strand is excised beyond the mismatch, DNA 
resynthesis occurs through the catalysis of the polymerase δ [50], in the presence of 
PCNA [56] and RPA [52]. The remaining nick is then sealed by an unidentified ligase, 
completing the repair process [2]. 
    Increasing evidence suggests that PCNA plays an important role in the MMR 
process. As a cofactor that greatly enhances the processivity of DNA polymerase δ, 
PCNA is required for DNA resynthesis in MMR [56]. Work by Umar et al. [121] 
suggested a role for PCNA in MMR at a step prior to DNA resynthesis. Subsequently, 
PCNA was found to physically interact with MSH6 and MSH3 [58, 65, 66]. More 
recently, PCNA has been shown to transfer MutSα to the mismatched site [67]. 
Additionally, other studies suggest that PCNA also binds to many different kinds of DNA 
replication and repair proteins [128, 129], including FEN1. However, the involvement of 
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PCNA in MMR initiation/excision is still not fully understood.  
The data derived from the time course of protein pull-down assay and the time 
course of mismatch excision assay show that the dramatic increase of PCNA binding to 
heteroduplex DNA is associated with the appearance and increase of mismatch excision 
products (see Chapter 3), suggesting that PCNA may play a role in regulating 
mismatch-provoked excision.  
In both E.coli and human cell, mismatch excision is a single strand nick-directed 
process. The nick can be located either 5’ or 3’ to the mismatch. Therefore, the mismatch 
excision occurs in either 5’ → 3’ direction or 3’ → 5’ direction. To understand the roles of 
PCNA in mismatch excision, 3’ and 5’ excision assay and repair assay by the MMR 
system in HeLa nuclear extract were performed in the presence and absence of p21, a 
protein that binds to PCNA and blocks its functions in DNA replication and repair [56, 
109, 121, 130]. The results show that while 3’ nick-directed mismatch removal is 
completely inhibited by p21, 5’ nick-directed mismatch excision is only partially reduced 
under the same conditions. The results suggest a differential role of PCNA in 5’- and 3’- 
directed mismatch excision. We further find that there is one pathway for 3’- directed 
mismatch excision, i.e., the PCNA-dependent pathway, and that there are at least two 
pathways for 5’-directed mismatch excision: one is PCNA independent; the other is 
PCNA dependent. 
Identification of PCNA-dependent mismatch-directed 5’ excision was performed by 
Dr. Fenghua Yuan [57].  
In this study, purified p21, p21C (a GST-p21C), and p21N (a GST-P21N) were 
kindly provided by Dr. Steven Presnell. 
 - 43 -
RESULTS 
p21 inhibits DNA MMR 
    p21Cip1/WAF (p21) binds tightly with PCNA through the inter-domain connecting loop 
and C-terminus of PCNA. This interaction prevents PCNA from binding to other proteins, 
such as DNA polymerase δ [128, 129, 131], to block PCNA’s function in MMR [56, 121], 
DNA replication, and other DNA metabolic pathways [109, 130]. To test the efficiency of 
the purified p21 in inhibiting DNA mismatch repair in these experiments, 5’ and 3’ 
nick-directed mismatch repair by HeLa nuclear extract was performed while adding 
increasing amounts of recombinant p21 in the reactions. In the repair products of 3’ 
nicked G/T substrate, NsiI restriction site is recovered. As a result, the repair products can 
be digested by both NsiI and BseRI to yield two fragments (Figure 4.1, lane 1). In the 
repair products of 5’ nicked G/T substrate, HindIII restriction site is recovered. As a result, 
the repair products can be digested by both HindIII and BspDI to yield two fragments 
(Figure 4.1, lane 6). With the increase of p21 in the reaction, the repair products decrease 
for both 3’ nicked G/T substrate (Figure 4.1, lane 1 to 5) and 5’ nicked G/T substrate 
(Figure 4.1, lane 6 to 10). MMR activity in HeLa nuclear extract is inhibited at p21 
concentration of 1.1 µM or higher. These data indicate that the purified, recombinant p21 
is active.  
 
 
 
 
 
 
 
 
 
Figure 4.1 p21 inhibits DNA MMR of both 3’ and 5’ nicked heteroduplex. 23 fmol of either 3’ G/T or 
5’ G/T substrates was incubated with HeLa nuclear extract at 37°C for 20 min in the presence of the 
indicated amount of p21. After reaction, recovered DNA was digested with BspDI and HindIII (for 5’ 
G/T) or with NsiI and BseRI (for 3’ G/T), and separated on 1% agarose gel (see Materials and Methods). 
Repair products 
0  0.5  1.1  2.2  3.4 0  0.5  1.1  2.2  3.4 
3’ nicked G/T 5’ nicked G/T 
p21 (µM) 
 1  2  3   4  5   6   7  8   9  10 
Repair products 
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p21 completely inhibits 3’ but not 5’ nick-directed mismatch-provoked excision. 
A characteristic of MMR-associated excision is that the process starts at the strand 
break, proceeds to the mismatch along the shorter distance between the two sites, and 
stops at a point ~ 150 nt beyond the mismatch, thereby generating a single stranded gap 
on the substrate [122]. Taking advantage of this property, we constructed nicked circular 
heteroduplex substrates that contain a restriction endonuclease site immediately 3’ or 5’ 
(depending on the excision orientations) to the mismatch (Figure 2.1). Thus, under 
conditions of limited DNA resynthesis (i.e., in the absence of exogenous dNTPs), 
orientation-specific excision by MMR could be scored by conversion of the restriction 
sequence (NheI for the 5’ substrate and HindIII for the 3’ substrate) from dsDNA to 
ssDNA, rendering the DNA resistant to the enzyme [49, 116].  
    To test the effect of p21 on the excision of 3’ and 5’ substrates, a time course of 
mismatch-provoked excision by HeLa nuclear extract was performed in the presence or 
absence of 1.1 µM of p21. After reaction, recovered DNA was scored by restriction 
enzymes (NheI and BspDI for the 5’ substrate, HindIII and BseRI for the 3’ substrate). As 
shown in Figure 4.2, at time 0, almost the entire DNA substrate (both 5’ and 3’ substrates) 
could be digested into two smaller fragments (see all reactions at 0 min), indicative of no 
generation of ssDNA gap (i.e., no excision). As incubation time increased, reactions 
without exogenous p21 accumulated a larger molecular weight DNA species for both the 
5’ and 3’ substrates, suggesting that a single strand gap extended from the pre-existing 
strand break, beyond the HindIII (3’ substrate) or NheI (5’ substrate) site since the 
excision products were resistant to digestion by the corresponding scoring enzymes 
(Figure 4.2 A&C). At 25 min, the accumulation of the larger species of DNA reached a 
plateau, with 40% and 32% for 3’ and 5’ nicked G/T substrates, respectively. Interestingly, 
when p21 was added to the reaction to inhibit the function of endogenous PCNA, there 
was a large difference in nick-directed, mismatch-provoked excision between reactions 
containing 5’ and 3’ substrates. For the 3’ substrate, p21 at a concentration of 1.1 µM 
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reduced gapped molecules by ~ 75% (compare Figure 4.2 A with B). However, little 
reduction in gapped molecules was detected in reactions containing the 5’ substrate under 
the same conditions (compare Figure 4.2 C with D). These results suggest a differential 
requirement for PCNA in 5’ and 3’ nick-directed, mismatch-provoked excision.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2 p21 differentially blocks orientation-specific excision in MMR. 3’ or 5’ nicked substrate 
was incubated with HeLa nuclear extract in the absence of exogenous dNTPs at 37 °C, and reactions 
were stopped at various time points for analysis. DNA was purified and digested with two restriction 
enzymes (Hind III and BseRI for 3’ substrate, and Nhe1 and BspD1 for 5’ substrate), and 
electrophoresed on 1% agarose gels to analyze the extent of strand excision. Formation of the top band 
(indicated by arrows) indicates the loss of a restriction enzyme site (HindIII for 3’ substrate, and Nhe I 
for 5’ substrate) due to excision of the nicked strand beyond this site. (A), reactions with 3’ nicked G/T 
in the absence of p21; (B), reactions with 3’ nicked G/T in the presence of p21(1.1 µM); (C), reactions 
with 5’ nicked G/T in the absence of p21; (D), reactions with 5’ nicked G/T in the presence of p21 (1.1 
µM).  
+ p21 
time(min) 0   2   4   6  15  25 0   2   4   6  15  25 
3’G/T 
Excision (%)   0    6  12  19  35  40   1   1   2   3  6  11 
5’G/T 
Excision (%)   1    6  12  22  19  32  1   6  11  22  21  29 
- p21 
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To confirm the results obtained with the full-length p21 protein, a fusion protein 
(p21C) containing the C-terminal portion of p21, a domain that is known to bind to 
PCNA with very high affinity (kD = 17 nM, [110]), was used in 5’ and 3’ mismatch 
excision assay. The excision products and un-reacted substrate shown on agarose gel 
were quantitated using NIH image 1,63f. The percentage of excision is plotted with the 
increase of p21C. As shown in Figure 4.3, the p21C protein can inhibit the excision of the 
3’ nicked G/T substrate at a concentration as low as 0.3 µM, however, p21C cannot block 
the excision of 5’ nicked G/T substrate as efficiently as the 3’ nicked G/T substrate 
(Figure 4.3), even concentrations of p21C as high as 9 µM (data not shown). It was 
observed that about 25% to 30% of 5’ nick-directed excision is sensitive to p21C (Figure 
4.3). 
 
 
 
 
 
 
 
 
 
 
 
Considering that many nucleases exist in HeLa nuclear extract, MMR independent 
excision of the 5’ and 3’ substrates used in this study can occur [106, 123]. To determine 
whether the 5’→3’ excision as described above is mismatch dependent or not, 5’→3’ 
excision of 5’ nicked G/T and 5’ nicked A/T (structure in Figure 2.1&2.2) was performed 
using MMR proficient (HeLa) and MMR deficient cell (N6 and H6) nuclear extracts, in 
Figure 4.3 The effect of p21-C on 3’ or 5’ 
mismatch substrate excision. The 
experiment was performed as in Figure 4.3 
but adding the increased amount of p21-C 
in the reaction. Excision products were 
scored by the restriction enzymes and 
quantitated using NIH image 1.63f (See 
Materials and Methods). Error bars 
represent the standard deviation of the 
mean (n=3). 
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the presence and absence of p21. As expected, the MMR proficient cell nuclear extract 
excised 5’ nicked G/T substrates efficiently, with p21 blocking about 18% of the excision 
activity (Figure 4.4, lanes 1 vs. 2). But the excision activities of MMR deficient cell 
nuclear extract on 5’ nicked G/T substrates are very low (less that 7%, Figure 4.4, lanes 3 
& 5). Although HeLa and N6 cell nuclear extract can perform limited amount (~9%) of 5’ 
→3’ mismatch independent excision activity, that activity is inhibited by p21 (Figure 4.4, 
lane 7 vs. 8 and 9 vs. 10). This data indicates that the remaining 5’ →3’ excision activity 
(Figure 4.3) in HeLa cell nuclear extract in the presence of p21C is mismatch-directed.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PCNA is required for the excision of 3’ mismatch substrates  
    To confirm that p21 inhibits the excision of 3’ mismatch substrates by blocking 
PCNA function and to visualize excision intermediates directly, mismatch excision was 
performed under conditions of limited DNA synthesis [116, 122]. Recovered DNA was 
digested with SspI (5’substrate) or SspI-DraIII (3’substrate) and excision intermediates 
Figure 4.4 Excision of 5’ nicked G/T and 5’ nicked A/T by MMR proficient and deficient cell 
nuclear extract. 23 fmol of DNA substrates were incubated with 50 µg of nuclear extract in the 
presence or absence of 1.1µM p21 under limited DNA synthesis condition at 37°C for 20 min, and 
excision was scored by the resistance of DNA substrates to NheI as described above. HeLa: MMR 
proficient. N6 and H6: MMR deficient. 
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were detected using Southern blot with a probe that hybridizes at a site on the nicked  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
strand beyond the mismatch (see the position of probe in Figure 2.1). As shown in Figure 
4.5, nicked strands that undergo mismatch-provoked excision are indicated by the 
Figure 4.5 Different requirements 
for PCNA in 3’ and 5’ mismatch 
repair in human MMR cells. 3’ (A) 
or 5’ (B) nicked G/T substrate was 
incubated with HeLa nuclear extract 
in either the absence (lane 5-7) or 
presence (lane 2-4) of exogenous 
dNTPs at 37 °C for 20 min. 
Recovered DNA was subjected to 
Southern blot. For 5’ nicked G/T, 
samples were digested with SspI and 
Hind III to visualize repair products 
(lane 2-4), or SspI to visualize 
excision intermediates (lane 5-7); For 
3’ nicked G/T, samples were digested 
with SspI, DraIII and NsiI to 
visualize repair products (lane 2-4), 
or SspI and DraIII to visualized 
excision intermediates (lane 5-7); 
Lane 1 in (A) or (B) is a marker 
indicating the fragment that spans 
from the nick to the SspI site for 
either 3’ or 5’ substrate.  
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appearance of shorten fragments on the gel (Figure 4.5 A, lane 5 for 3’ G/T and Figure 
4.5 B, lane 5 for 5’ G/T) as compared to the nick strand of the un-reacted substrate 
(Figure 4.5 A, lane 1 for 3’ G/T and Figure 4.5 B, lane 1 for 5’ G/T) under conditions of 
limited DNA synthesis, indicative of the occurrence of strand excision. For the 3’ G/T 
substrate, this fragment pattern disappears upon addition of p21C to the reaction (Figure 
4.5 A, lane 6), suggesting that excision of the 3’-substrate is inhibited by p21C in these 
conditions. The p21C inhibition reaction can be rescued by the addition of excess PCNA 
to the mixture (Figure 4.6 A, lane 7). In contrast to the results seen for the 3’-substrate, 
the 5’-substrate undergoes excision in the presence of p21C at level similar to that seen in 
the absence of the fusion protein (compare lanes 5, 6 & 7, Figure 4.5 B). These 
observations further suggest that either no PCNA, or much less PCNA is required in a 
step either during or prior to excision for a 5’-substrate, compared with the 3’ substrate. 
 
PCNA is required for DNA resynthesis step of the 5’ mismatch substrate 
As shown in Figure 4.1 and Umar et al. [121], p21 inhibits the repair of both 5’ and 
3’ nick-containing mismatch substrates. However, Figure 4.2, 4.3, and 4.4 show that p21 
inhibits the excision of 3’ mismatch substrate efficiently, but this is largely not the case 
for 5’ substrate. These data indicate that p21 might block the repair of 5’ mismatch 
substrate at the DNA resynthesis step.  
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Figure 4.6 p21 and p21C, but not p21N, 
inhibit DNA synthesis (gap filling). A 171-
nt gapped substrate (as shown in Figure 2.2) 
was incubated with HeLa nuclear extract in 
the presence of dNTPs and in increasing 
concentrations of p21, p21C, or p21N at 
37°C for 20 min. DNA synthesis was scored 
by the recovery of the HindIII site, and
quantitated using NIH Image 1.63f.  
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To confirm this, DNA synthesis by HeLa nuclear extract was performed using a 
171-nt gapped dsDNA substrate (see Figure 2.2) in the presence of increasing 
concentrations of p21, or p21C, or p21N at 37°C for 20 min. The gap filling products 
were scored by the recovery of HindIII restriction site, and quantitated using NIH image 
1.63f. The percentage of DNA synthesis is plotted with the concentration of p21, p21C 
and p21N. As shown in Figure 4.6, the percentage of DNA synthesis decreases with the 
increase of p21 and p21C in the reactions, but p21N does not affect resynthesis. These 
data suggest that p21 and p21C, but not p21N, inhibit DNA synthesis by HeLa nuclear 
extract. Similar to the results seen for mismatch excision, p21C inhibits DNA synthesis 
much more efficiently than p21 (Figure 4.6 and [110]). Because p21N does not have a 
PCNA binding domain, it is likely that p21 and p21C inhibit the repair of 5’ mismatch 
containing-substrate at the DNA resynthesis step by blocking PCNA function. 
     To test this, repair of 3’ and 5’ mismatch substrates was carried out in the presence 
of exogenous dNTPs, and repair products were assayed for the formation of a 
homoduplex at the mismatch site by virtue of their sensitivity to NsiI (3’ G/T), or HindIII 
(5’ G/T), followed by Southern blot analysis. As expected, a band (487 nt in length for 3’ 
nicked G/T and 414 nt for 5’nicked G/T; see lane 2 in Figure 4.5 A and Figure 4.5 B, 
respectively) representing the repaired products was detected under normal conditions. 
When p21C was added to these reactions, the band representing the repair products was 
not detected for either substrate (land 3 in Figure 4.5 A and Figure 4.5 B for 3’ and 5’ G/T, 
respectively). For the 3’ substrate, two major NsiI-resistant bands were observed; the top 
band (964 nt) was the directly ligated substrate, and the lower band was the un-reacted 
nicked substrate (Figure 4.5 A, lane 3). For 5’ substrate, many bands smaller than 544 nt 
were evident, indicative of the formation of excision intermediates (Figure 4.5 B, lane 3). 
This result suggests that the excision step occurred in the presence of p21C, but the DNA 
resynthesis was inhibited although the reactions contained exogenous dNTPs. However, 
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the defect in DNA resynthesis was restored by the addition of excess amount of 
exogenous PCNA to the reaction (Figure 4.5 B, land 4), as judged by the disappearance 
of the excision intermediates and the appearance of the repair product, i.e. the 414-nt 
band. These observations indicate that PCNA is completely required for the DNA 
resynthesis step of the repair of 5’ mismatch substrate.  
 
p21 inhibits gap-directed 5’ → 3’ homoduplex excision 
After excision passes through the mismatch site, a single-stranded gap will be 
generated for both the 3’ and 5’ nicked mismatch-containing substrates. Interestingly, for 
the 3’ substrate, a definite point of excision termination (about 20 to 30 nt beyond 
mismatch) occurs after the mismatch is removed (Figure 4.5 A, lane 5). But for the 5’ 
substrate, there is no strong or obvious excision termination point after the mismatch is 
removed, and excision termination appears to be indefinite, proceeding as far as several 
hundred nucleotides beyond the mismatch (Figure 4.5 B, lane 5). However, the presence 
of p21C in the reaction induces the appearance of a definite excision point (Figure 4.5 B, 
lane 6). These data suggests that 5’→3’ mismatch-independent excision activity in HeLa 
nuclear extract may exist (as described in [106, 123]), and the activity might be 
PCNA-dependent. To investigate this more carefully, a substrate that lacked a mismatch 
but contain a small (35 nt) single strand gap was constructed (see Figure 4.7). Excision 
was performed using this gap-containing homoduplex substrate in the presence of the 
increased amount of p21. The formation of a higher molecular weight NheI-resistant 
species of the gapped homoduplex substrate indicates that 5’→3’ gap-directed 
homoduplex excision has passed through the NheI site (Figure 4.7 left panel). The 
formation of a higher molecular weight SwaI-resistant species of the gapped homoduplex 
substrate indicates that 3’→5’ gap-directed homoduplex excision has passed through the 
SwaI site (Figure 4.7 right panel). As shown in Figure 4.7, 5’→3’ mismatch-independent 
excision (about 50%) occurs strongly compared with 3’→5’ mismatch-independent 
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excision (less than 3%), and 5’→3’ homoduplex excision activity in HeLa cell nuclear 
extract was inhibited by p21 significantly, which is consistent with the observation in 
Figure 4.6 A lane 6.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Partial Reconstitution of the PCNA-dependent 5' Excision**  
      Although the 5' nick-directed mismatch excision is much less sensitive to p21 or 
p21C as compared with the 3' nick-directed excision, the addition of p21C at a relatively 
low concentration (0.6 µM) reduced the 5' nick-directed excision by 30%, suggesting an 
involvement of PCNA in the reaction. To explore this possibility, we utilized a partially 
purified phosphocellulose fraction (PF) that is required for mismatch-provoked, 
nick-directed excision in in vitro MMR. We incubated this fraction along with a 5' G-T 
substrate in the presence or absence of exogenous MutSα or PCNA. As shown in Figure 
4.8, either PF alone or PF with either exogenous MutSα or PCNA catalyzed minimal  
 
                                                        
** This work was performed by Drs. Fenghua Yuan and Yanbin Zhang and published in [57]. 
Figure 4.7 Effect of p21 on 3’ and 5’gap-directed mismatch-independent excision. Gapped (35 nt) 
homoduplex substrate was incubated with HeLa nuclear extract in the absence of exogenous dNTPs at 37 
°C for 20 min in the presence of different concentration of p21. Recovered DNA was digested with two 
restriction enzymes (SwaI and BspDI for 3’→5’, and NheI and BspDI for 5’→3’), and electrophoresed 
on 1% agarose gels to analyze the extent of strand excision. Formation of the top band (indicated by 
arrow) indicates the loss of a restriction enzyme site (SwaI for 3’→5’, and NheI for 5’→ 3’) due to 
excision of the nicked strand beyond this site.  
5’ HD (NheI/BspDI) 3’ HD (SwaI/BspD1) 
p21 (µM) 0   0.5  1.1  2.3  3.4  9.0 0   0.5  1.1  2.3  3.4  9.0
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** This work was performed by Drs. Fenghua Yuan and Yanbin Zhang and published in [57]. 
 
Figure 4.8 Involvement of PCNA in 5' nick-directed excision. DNA substrates were incubated with 
reaction mixtures containing different combinations of 1.5 µg of a PF, 26 nM MutSα, and 67 mM PCNA, 
as indicated, for 20 min at 37 °C. DNA products were digested with NheI and BspDI (5' substrate) or 
HindIII and BseRI (3' substrate) to score for the generation of gapped molecules as described under 
"Experimental Procedures." When present, p21C concentration was 0.06, 1.6, or 4.8 µM, and bovine 
serum albumin (BSA) was 100 ng. PF was obtained by fractionating HeLa nuclear extracts in a 
phosphocellulose column. Briefly, HeLa nuclear extracts were loaded onto a phosphocellulose column 
equilibrated with buffer A (20 mM Hepes, pH 7.6, 2 mM dithiothreitol, 1 nM phenylmethylsulfonyl 
fluoride, 1 mM EDTA, and 1 µg/ml leupeptin) containing 0.1 M KCl. After extensive washing with 
buffer A containing 0.3 M KCl, the column was eluted with the same buffer containing 0.35 M KCl. The 
protein peak fractions were pooled, concentrated, and stored in small aliquots at –80 °C before use. A, 
comparison of 5' nick-directed excision between a heteroduplex and a homoduplex in the partially 
reconstituted reaction. B, 3' nick-directed excision in the partially reconstituted system. 
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amounts of excision activity on the 5' G-T substrate (lanes 2–4). However, when all three 
components were mixed together (lane 5), 5' nick-directed excision was significantly 
stimulated compared with the levels found for the two component mixtures (PF-PCNA or  
PF-MutSα). Notably, the level of excision using this partially purified extract and purified 
proteins reached a level that was even higher than that found for the whole cell nuclear 
extract. The stimulation of excision in this reaction, however, was completely inhibited by 
p21C (Figure 4.8 A, lanes 7 and 8); hence, our results suggest that the PF-catalyzed 
excision activity requires both MutSα and PCNA 
     Similar experiments were performed using a 5' A-T homoduplex as a substrate in 
otherwise identical conditions. Excision of this substrate was minimal with PF alone or 
PF incubated with either MutSα or PCNA. However, unlike that seen for the 
heteroduplex, excision was not stimulated by the addition of all components beyond the 
levels seen for the two component mixtures (PF-PCNA or PF- MutSα; Figure 4.8 A, 
lanes 10–12), and the excision was insensitive to p21C (lanes 13–15). These results 
indicate that the homoduplex-directed excision is a nonspecific excision and that the 5' 
nick-directed MutSα- and PCNA-dependent excision must occur in a manner dependent 
on a mismatch. The PF fraction was unable to catalyze any 3' nick-directed excision 
(Figure 4.8 B), and this result likely occurs because the fraction does not contain any 
3'-directed exonucleases. From these results (Figure s4.1) and the fact there is a 
considerable amount of 5'-directed and mismatch-provoked excision that is not blocked 
by p21C (Figure 4.3), we conclude that there are at least two types of 5' nick-directed 
mismatch excision in human cells, one that is dependent on PCNA and another that is not. 
 
p21 inhibits PCNA to bind to DNA 
    It has been shown that p21 blocks the function of PCNA by binding in such a way as 
to interfere with the binding of other proteins [128, 129]. To directly test whether p21 
affects the binding of PCNA to DNA, PCNA and DNA polymerase δ pulled-down by 
both 3’ and 5’ heteroduplex DNA from HeLa nuclear extract in the presence and absence 
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of p21 were detected. As shown in Figure 4.8, p21 inhibits PCNA from binding to either 
the 3’ or 5’ heteroduplex dramatically, but does not affect the binding of DNA polymerase 
δ to DNA. This data suggest that p21 also blocks PCNA activity by preventing it from 
binding to DNA.  
 
 
 
 
 
 
 
Figure 4.9 Effect of p21 on the binding of PCNA to 3’ and 5’ heteroduplex. Pull-down assay of 
DNA polymerase δ, and PCNA from HeLa nuclear extract in the presence or absence of p21 by 
either 3’ or 5’ heteroduplex.. 
w/o p21 w/ p21
3’ A/C 5’ G/T 
Time 1   4   8  20  1   4   8  20 
polδ
PCNA 
1   4  8  20  1   4   8  20 
w/o p21 w/ p21 
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DISCUSSION 
In this chapter, the data demonstrated a differential requirement for PCNA in 3’ 
versus 5’-nick directed mismatch repair at a step prior to DNA resynthesis, suggesting 
that distinct mechanisms are used for mismatch excision from different orientations. 
Although PCNA is required at the DNA resynthesis step of 3’ and 5’ MMR (Figure 4.5 
A&B and Figure 4.6), the requirement for PCNA at the excision step of 3’ and 5’ MMR is 
different. As shown in Figures 4.2, 4.4, and 4.5, PCNA is completely required for 3’ 
nick-directed mismatch excision, but not essential for 5’ nick-directed mismatch excision.  
Our conclusions derived from the experiments using p21 as a PCNA inhibitor have 
been recently confirmed through the use of purified recombinant proteins instead of 
nuclear extract [59, 62]. Recently, Yuan found that a HeLa nuclear extract fraction could 
perform PCNA-dependent 5’ mismatch excision but not 3’ mismatch excision (Figure 
4.8). In addition, we also find that a 5’→3’ mismatch-independent excision activity exists 
in HeLa nuclear extract, and this activity is PCNA-dependent (Figure 4.5 B and Figure 
4.7). Therefore, the roles of PCNA in 3’ and 5’ mismatch excision can be summarized as 
follows: (1) In 3’ nicked mismatch substrate, PCNA is required for 3’→5’ mismatch 
excision, and that there is no strong 3’→5’mismatch-independent excision that occurs 
(Figure 4.7); for these reasons, excision is stopped shortly after the mismatched base is 
removed (Figure 4.5 A, lane 5 & 7). (2) In 5’ nicked mismatch substrate, mismatch 
excision can occur through both a PCNA-independent pathway (Figure 4.6 B) and a 
PCNA-dependent pathway (Figure 4.8). However, 5’→3’excision cannot stop 
immediately after mismatch is removed (Figure 4.5 B, lane 5 and 7). A reason for this 
could be due to a moderate amount of 5’→3’ gap-directed homoduplex excision that 
occurs after mismatch is removed (Figure 4.7).  
Human Exo1, a 5’→3’ exonuclease, is required for human MMR [49]. Recent 
studies show that Exo1 catalyzes 5’→3’ mismatch excision in a PCNA-independent 
manner [62] and catalyzes 3’→5’ mismatch excision in a PCNA and RFC-dependent 
manner [59]. These observations are consistent with some of our observations: the 
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existence of a 5’ PCNA-independent mismatch excision pathway and 3’ 
PCNA-dependent mismatch excision pathway in HeLa nuclear extract. However, in vitro 
reconstitution experiments performed by Yuan et al showed that HeLa nuclear extract 
contains a 5’→3’ PCNA-dependent mismatch excision activity, and this activity cannot 
be replaced by Exo1 (Figure 4.8, and Yuan and Li, unpublished data). Based on these 
results, it is possible that there are at least two nucleases that are involved in 5’ 
nick-directed mismatch excision in human MMR, i.e. one whose activity is not enhanced 
by (or requires) PCNA (i.e. Exo 1), and another whose activity is enhanced by (or require) 
PCNA. The latter nuclease has yet to be identified.  
Evidence from recent Exo1 knockout studies also supports this hypothesis [76]. First, 
Msh2-/- mice display Hprt (hypoxanthine guanine phosphoribosyl transferase) mutability 
5 fold higher than that of Exo1-/- mice. Second, Exo1-/- cells possess residual repair 
activity (~20% compared with wild type) on a 1-nt insertion/deletion mispair, a 
heteroduplex that is believed to be processed only by the MMR pathway. Finally, whereas 
all Msh2-/- mice were dead of cancer by 12 months of age, only 50% of ExoI-/- mice died 
at 17 months [76]. In addition, intestines from the patients with Exo1 mutation do not 
show MSI (microsatellite sequence instability). as seen from the patients with a MSH2 or 
MLH1 mutation [132]. The weaker mutator phenotype and reduced tumorgenicity of 
Exo1-/- cells suggest that MMR activity is not completely blocked by Exo1 mutation, 
which is consistent with the hypothesis that Exo1 is not the only nuclease involved in 
mammalian MMR. Additionally, evidence from yeast studies showed that, in addition to 
Exo1, other nucleases, such as Rad27 (also called Rth1, a FEN-1 homolog) and the 
exonuclease activities associated with DNA polymerase δ and ε, may also function at the 
excision step of MMR [133-135].  
Mismatch excision requires an assembly of MMR initiation factors at the mismatch 
site, followed by recruitment of exonuclease(s) to execute excision. PCNA has been 
shown to interact with human MutS and MutL homologs [121] and may function to 
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recruit these proteins to the mismatch site [66], indicating an involvement of PCNA in the 
assembly of the MMR initiation complex. On the other hand, PCNA may help to recruit 
or activate exonuclease(s) as suggested by Modrich’ model [59]. This hypothesis is 
supported by the observation that PCNA is known to interact with and greatly enhance 
the activity of FEN-1 [136, 137], a nuclease that plays a role in BER [138], and that 
PCNA may be capable of interacting with other nucleases. However, the pull-down assay 
demonstrates that p21 inhibits the binding of PCNA to both 3’ and 5’ heteroduplex 
(Figure 4.9), and excision assay show that p21 inhibits 3’ mismatch excision, but not for 
5’ mismatch excision. These data suggest that the different orientation effect of PCNA in 
mismatch excision is due to PCNA involvement in mismatch excision but not mismatch 
recognition [59].   
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CHAPTER 5. Phosphorylation of RPA2 Facilitates MMR at DNA Resynthesis Step  
 
INTRODUCTION 
    Replication protein A (RPA) is a ssDNA binding protein and it consists of three 
subunits, 70kD (RPA1), 32kD (RPA2), and 14kD (RPA3) [78, 139]. RPA is essential for 
many DNA metabolic pathways, including DNA replication, DNA repair, and 
recombination [139], and DNA damaging signaling [140].  
    Analysis of RPA structure shows six DNA binding domains with four in RPA1 
(domains A, B, C, and F), one each in RPA2 (domain D) and RPA3 (domain E). Domains 
A, B, C, and D are critical for the binding of RPA to DNA and the formation of a stable 
ssDNA-RPA complex [141-143]. 
    RPA2 can be phosphorylated by DNA-dependent protein kinase (DNA-PK) [144] 
and ATM [118] during DNA replication [100, 144, 145] and in response to DNA damage 
[101-105]. The phosphorylation site is located in the N-terminal region (residues 1 ~ 35) 
of RPA2 that contains eight serine and one threonine. 
Our previous paper has shown that RPA is required for MMR in both excision and 
DNA resynthesis steps [52]. In Chapter 3, a time course of protein pull-down showed that 
RPA binds to nicked heteroduplex DNA as early as the binding of MutSα to the DNA, 
consistent with a role for RPA in mismatch-provoked excision. The results also show that 
RPA2 is phosphorylated during MMR. Specially, phosphorylation of RPA2 is associated 
with the binding of DNA polymerase δ to heteroduplex DNA, and with the appearance of 
repair products. Therefore, we hypothesize that that RPA2 phosphorylation functions in 
DNA resynthesis.  
To test this, a 171-nt gapped circular DNA substrate was used for DNA polymerase 
δ-catalyzed gap filling in the presence of RPA or phosphorylated RPA. This gap substrate 
mimics the ssDNA gap generated during mismatch-provoked excision as described [52]. 
The gap-filling assays were performed using both a cell-free system and a purified 
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system. The results suggest that RPA2 phosphorylation greatly facilitates gap filling 
catalyzed by DNA polymerase δ on RPA-protected template.  
Recently, Oakley and co-workers have shown that phosphorylation of RPA2 
decreases its dsDNA binding activity [146]. According to this, the molecular mechanism 
for RPA2 phosphorylation facilitating gap filling catalyzed by DNA polymerase δ on 
RPA-protected template might be due to that RPA2 phosphorylation decreases the ssDNA 
binding ability of RPA. It is difficult to test the difference between the ssDNA binding 
ability of RPA and that of phosphorylated RPA using the EMSA (electrophoretic mobility 
shift assay) [146, 147]. In this study, the competition between RPA and phosphorylated 
RPA for ssDNA binding was detected using protein pull-down assay with Western blot. 
The data indicates that RPA phosphorylation reduces the ssDNA binding ability of RPA. 
To further measure the kinetic constants of RPA for ssDNA binding, the stop-flow assay 
was performed with the help of Dr. Isaac Wong (University of Kentucky) [117]. These 
data suggest that RPA phosphorylation decreases the kon value of RPA and increases the 
koff value of RPA.      
Therefore, the stimulation of DNA resynthesis by RPA2 phosphorylation on 
RPA-protected template is likely due to the fact that phosphorylation reduces the ssDNA 
binding ability of RPA and potentiates the release of RPA from DNA during DNA 
resynthesis, thereby making DNA template available for DNA polymerase δ. 
In this study, the purified DNA polymerase δ and DNA-PK were kindly provided by 
Dr. FenghuaYuan (University of Kentucky). RPA and phosphorylated RPA purified from 
HeLa cell nuclear extract were kindly provided by Dr. John Turchi (Wright State 
University).  
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RESULTS 
Wortmannin inhibits RPA2 phosphorylation and gap filling in HeLa nuclear extract 
    DNA-PK and ATM phosphorylate RPA2 both in vitro and in vivo [101-103, 105, 118, 
144, 148]. The kinase activity of DNA-PK and ATM can be inhibited by Wortmannin, an 
inhibitor of PI-3 kinase family [149, 150]. To test at which concentration of Wortmannin 
RPA2 phosphorylation is inhibited, RPA2 pulled down by resin-bound linear nicked 
heteroduplex from HeLa nuclear extract in the presence of different concentration of 
Wortmannin was detected using Western blot. The results show that 4.1 µM of 
Wortmannin completely blocked RPA2 phosphorylation which binded to DNA (Figure 
5.1 A).   
    To test how RPA2 phosphorylation affects DNA resynthesis, DNA gap filling assays 
were performed using a 171-nt gapped substrate (Figure 5.1 B) and HeLa nuclear extract 
in the presence or absence of 4.1 µM of Wortmannin. A successful gap filling would 
render the DNA substrate sensitive to HindIII. Therefore, this synthesis product can be 
digested by both HindIII and BspDI to yield two small fragments. As shown in Figure 5.1 
C, in the absence of Wortmannin, DNA synthesis increased proportionally with 
incubation time (Figure 5.1 C top panel. DNA synthesis products, 3.1 kb and 3.3 kb, were 
indicated by arrows). DNA synthesis was also observed in HeLa nuclear extract 
supplemented with 4.1 µM of Wortmannin (Figure 5.1 C bottom panel. DNA synthesis 
products, 3.1 kb and 3.3 kb, were indicated by arrows), but less than observed in the 
reaction without Wortmannin. The products in the presence and absence of Wortmannin 
were quantitated using NIH image 1.63f, and plotted with the reaction time. The results 
show that with the increase of reaction time, wortmannin slows down the level of DNA 
synthesis significantly (P<0.01) (Figure 5.1 D). To visualize the synthesis products 
directly, DNA gap filling products were digested with SspI, and the fragments were 
detected using Southern blotting. As shown in Figure 5.1 E, whereas almost all substrates 
(fragment I) were converted to the full length products (Fragment III, gap filled and nick 
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Figure 5.1 Wortmannin inhibits DNA resynthesis (gap filling) in HeLa nuclear extract. (A) 
Wortmannin inhibits RPA2 phosphorylation. RPA2 pulled-down by nicked G/T from HeLa nuclear 
extract in the presence of different concentration of Wortmannin was detected with Western blot. (B) 
Structure of gap substrate. Black bar indicates the probe binding position. (C) Time course of gap filling 
by HeLa nuclear extract in the presence (bottom panel) and absence (top panel) of wortmannin: scored 
by the recovery of HindIII site. The synthesis products were indicated by arrows. (D) Quantitating DNA 
synthesis products. Panel B was quantitated with NIH Image 1.63f, products (fmol) = 36 (fmol) ×
[product/(product+substrate)]. Error bars represents the SD of mean (n=3). (E) Time course of gap filling 
by HeLa nuclear extract in the presence and absence of wortmannin: visualized using Southern blot. 
32Pi-probe binding site is shown in panel B. Fragment I is 165 nt, Fragment II is 336 nt (marker), and 
Fragment III is 744 nt. 
 
 
 
 
 
 
 
 
ligated) in HeLa nuclear extract without Wortmannin after 20 min of incubation, the full 
length products in the reaction with Wortmannin were greatly reduced (only 56%) for the 
same incubation time. These data indicate that phosphorylation of RPA2 helps facilitate 
DNA gap filling in HeLa nuclear extract.  
 
RPA2 Phosphorylation facilitates DNA gap filling in a defined system 
    To further determine the impact of RPA2 phosphorylation on DNA synthesis, DNA 
gap filling assay was performed using purified DNA polymerase δ, RPA2WT (purity 
shown in Figure 5.2 A), or/and DNA-PK, which can phosphorylate RPA2 (Figure 5.2 C) 
[144], in the presence or absence of Wortmannin. The synthesis products were detected 
using Southern blot. As shown in Figure 5.2 B, DNA polymerase δ by itself can fill the 
171-nt gap efficiently (~73%) (Figure 5.2 B, lane 1, fragment I). Addition of Wortmannin 
to the reaction does not inhibit gap filling by DNA polymerase δ (Figure 5.2 B, lane 2, 
fragment I). Interestingly, the in vitro gap filling by DNA polymerase δ is greatly 
inhibited by RPA2WT (Figure 5.2 B, lane 1 vs. Lane 3). The inhibitory effect of RPA2WT 
on gap filling activity of polymerase δ is attenuated by DNA-PK (Figure 5.2 B, lane 1 vs. 
lane 4 vs. lane 5) through which catalyzes RPA2 phosphorylation. Phosphorylation of 
RPA2 by DNA-PK in the presence and absence of Wortmannin was shown in Figure 5.2 
C. These observations indicate that RPA phosphorylation facilitates DNA synthesis on 
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RPA-protected template. 
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Figure 5.2 Phosphorylation of RPA2 facilitates gap filling by DNA polymerase δ on RPA-protected 
template. (A) The purity of RPA2WT, RPA2D, RPA2A, and Pi-RPA (Commassie blue staining). (B) 
DNA-PK attenuates the inhibitory effect of RPA on gap filling through RPA2 phosphorylation. The 
reactions were performed with indicated conditions at 37°C for 10 min using gap substrate (Figure 5.1 
B). The products were detected with Southern blot. Fragment I is product (336 nt), and Fragment II is 
substrate (165 nt). (C) Wortmannin inhibits the phosphorylation of DNA-bound RPA2. MMR reactions 
were performed in the presence of γ-32Pi-ATP at 37ºC for 20 min using resin-bound linear nicked G/T 
substrate. The proteins pulled down from HeLa cell nuclear extract (lane 1 with wortmannin, and lane 2 
without wortmannin) or RPA:DNA-PK mixture (lane 3 with wortmannin, and lane 4 without 
wortmannin) were subjected to 15% SDS-PAGE, and exposed to X-film. (D) Effects of RPA2A, RPA2D
and RPA2WT on gap filling. DNA polymerase δ (580 fmol) was incubated with circular gap substrate (46 
fmol) in the presence and absence of RPA2A (3.2 pmol) or RPA2D (3.2 pmol) or RPA2WT (3.2 pmol). The 
experiments were performed as in panel B. (E) Effects of native RPA and Pi-RPA on gap filling. DNA 
polymerase δ (580 fmol) was incubated with circular gap substrate (46 fmol) in the presence and absence 
of RPA (3.2 pmol) or Pi-RPA (3.2 pmol) at 37°C for 10 min. The products were analyzed by the recovery 
of HindIII site. Synthesis products are indicated by arrows.  
 
 
 
 
 
 
 
     
 
 
 
 
Recently, recombinant RPAs representing the hyperphosphorylated (RPA2D) or 
nonphosphorylated (RPA2A) forms of the protein have been constructed by replacing the 
serine (Ser) and threonine (Thr) residues with aspartic acid (Asp) and alanine (Ala) (see 
Figure 5.2 A), respectively. RPA2D has been shown to behave as hyperphosphorylated 
RPA in vivo and in vitro [147, 151].  
To determine how RPA2D, RPA2A, and RPA2WT (wild type RPA) affect DNA 
polymerase δ-catalyzed gap filling, time course of gap filling was performed using DNA 
polymerase δ and one kind of PRA. Recovered DNA was digested with SspI. The 
synthesis intermediates and products were detected using Southern blot. As shown in 
Figure 5.2 D, about 83% of gap substrate was converted to full length synthesis products 
in the absence of RPA after 12 min of reaction (Figure 5.2 D lane 4). RPA2D has little 
effect on the gap filling catalyzed by DNA polymerase δ (about 78% gap filling products 
was observed after 12 min of reation. Figure 5.2 D lane 10). However, RPA2A and 
RPA2WT slow down the gap filling catalyzed by DNA polymerase δ dramatically (Figure 
5.2 D lane 7 and 13). This data suggest that phosphorylation of RPA2 facilitates the gap 
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filling on RPA-protected template. To test this conclusion further, the effect of native RPA 
and hyperphosphorylated RPA isolated from HeLa cell nuclear extract on the gap filling 
catalyzed by DNA polymerase δ was scored using HindIII. The results show that RPA 
slows down the gap filling more efficiently than phosphorylated RPA does (Figure 5.2 E, 
lane 1, 3 and 4), supporting the conclusion derived from using recombinant RPAs. 
 
Phosphorylation reduces the ssDNA binding ability of RPA 
RPA binds to ssDNA generated during mismatch excision to protect it from nuclease 
digestion. In the last step of MMR, the ssDNA is used as a template by DNA polymerase 
δ for DNA resynthesis. The efficiency of RPA release from ssDNA during gap filling 
might affect the processing of DNA polymerase δ along the template. Therefore, we 
hypothesize that RPA2 phosphorylation reduces the ssDNA binding affinity of RPA. 
    To test the ssDNA binding ability of RPA and phosphorylated RPA, two kinds of 
competition among purified RPA2A, RPA2D, and RPA2WT were performed. First, 
RPA2A:RPA2D mixture or RPA2WT: RPA2D mixture was incubated with increased 
amounts of resin-bound biotinylated linear ssDNA (380 nt) at 37°C for 10 min. The 
pull-down results show that the beads cannot pull down RPA without ssDNA (Figure 5.3 
A, lane 1). Only RPA2A or RPA2WT binds to ssDNA and is pulled down from the 
mixtures at low ssDNA level (Figure 5.3 A, lane 2). Although RPA2D is pulled down with 
the increased amount of ssDNA, the amount is less than those of RPA2A or RPA2WT 
(Figure 5.3 A, lane 3, 4 and 5). Second, competition assay of RPAs was performed by 
challenging either RPA2A:ssDNA:beads complex or RPA2WT:ssDNA:beads complex with 
the increased amount of RPA2D, or challenging RPA2D:ssDNA:beads complex with the 
increased amount of either RPA2WT or RPA2A at 37°C for 10 min. RPA2 pulled down by 
ssDNA was detected using Western blot. As shown in Figure 5.3 B, RPA2D on 
RPA2D:ssDNA:beads complex can be replaced by both RPA2A and RPA2WT (bottom two 
panels), however, RPA2D cannot replace either RPA2A or RPA2WT from their DNA 
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complexes (top two panels). The competition assay using biotinylated 171 nt-gap 
homoduplex DNA shows similar results (data not shown). These data demonstrate that 
RPA2A and RPA2WT have higher ssDNA binding ability than RPA2D, which indicates that 
phosphorylation reduces the ssDNA binding ability of RPA. 
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Figure 5.3 RPA2A and RPA2WT have higher ssDNA binding ability than RPA2D. (A) RPA2A and 
RPA2WT bind to ssDNA more efficiently than RPA2D. RPA2 pulled down from either RPA2WT:RPA2D
mixture (top) or RPA2A:RPA2D mixture (bottom) by ssDNA (0,42,75,170 fmol) is detected with
Western blot. (B) RPA2D on ssDNA can be replaced by both RPA2A and RPA2WT. Top two panels:
RPA2A:ssDNA complex or RPA2WT:ssDNA complex was challenged with increasing amount of 
RPA2D. Bottom two panels: RPA2D:ssDNA complex was challenged with increased amount of either 
RPA2WT or RPA2A. RPA2 pulled down by ssDNA is detected with Western blot. (C) RPA2WT drives 
the release of 32Pi-RPA from gapped dsDNA more efficiently than RPA2D. DNA-PK-labeled 
32Pi-RPA:DNA:beads complex incubated with increased amount of RPA2WT or RPA2D (6, 12, 25, 50 
ng/µl) at 37ºC for 10 min.  32Pi-RPA in solution (s) and on DNA (b) was measured by scintillation 
counting, percentage of 32Pi-RPA binding = [b/(s+b)]×100. 
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    To confirm this further, 32Pi-RPA2WT:DNA:beads complex labeled by DNA-PK was 
challenged by adding the increasing amounts of either RPA2WT or RPA2D. After the 
reaction, DNA-bound 32Pi-RPA and free 32Pi-RPA (in solution) were measured by 
scintillation counting. The percentage of DNA-bound 32Pi-RPA as the function of RPA 
concentration is drawn in Figure 5.3 C. The results show that the percentage of 
DNA-bound 32Pi-RPA decreases with the increase of either RPA2WT or RPA2D in the 
reaction, but RPA2WT drives the release of 32Pi-RPA from DNA much more efficiently 
than RPA2D (Figure 5.4 C). These data further support that phosphorylation of RPA 
reduces its DNA binding affinity. 
 
RPA2 phosphorylation decreases kon value of RPA and increases koff value of RPA  
To determine how RPA2 phosphorylation decreases the ssDNA binding ability of 
RPA, the kinetic constants of RPA2A and RPA2D binding to ssDNA were measured using 
a KinTek stop-flow instrument.  
    The quenching of the intrinsic tryptophan fluorescence of constant amount of 
RPA2A or RPA2D (7.5 nM) was monitored over time with different DNA concentration 
(23.5, 39, 65, 108, 180, 300, and 500 nM). The excitation wavelength was set at 280 nm, 
and the emission was monitored via a 330-nm cut-on filter (See Material and Methods). 
The results reveal a DNA-dependent fluorescence quenching effect with ssDNA, and the 
results at 180 nM ssDNA are shown in Figure 5.4 A. The data fits to a single-exponential 
decay: Y=A1*e(-k1t) + C1 (kobs = k1). The values of A1, C1, and k1 were calculated using 
KinTek software (Figure 5.4 A). The observed rates of quenching, kobs, are 54s-1 (Figure 
5.4 A left panel) and 31s-1 (Figure 5.4 A right panel) for RPA2A and RPA2D, respectively. 
Assuming that constant RPA and varying DNA concentrations were used to achieve 
pseudo-first order kinetics, the observed rate (kobs) of quenching was plotted versus the 
DNA concentration for both RPA2A (Square) RPA2D (Diamond) (Figure 5.4 B). The 
results reveal a linear relationship with the slope being equal to the kon and the y-intercept 
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Figure 5.4 Determination of kon values for RPA2A- or RPA2D-binding to ssDNA (21-mer) using 
stop-flow kinetics assay. (A) Kinetics of RPA binding to ssDNA. Kinetic traces were measured at either 
RPA2A or RPA2D concentration of 7.5 nM and a DNA concentration of 180 nM (see Material and 
Methods). There is a time-dependent decrease in RPA intrinsic fluorescence (bottom trace). The kinetic 
traces are an average of 12~20 measurements at present DNA concentration, and fit to a 
single-exponential decay. The kobs values are 54 s-1 and 31 s-1 for RPA2A and RPA2D, respectively. The 
residual values obtained for each fit of the data are presented in the panel above the kinetic traces. (B) 
Determination of the kon values for RPA-binding to ssDNA. The observed rate constants of RPA2A or 
RPA2D were plotted versus DNA concentration of ssDNA (21-mer), and fit to a straight line. The slopes 
of the line provide the bimolecular rate constants, kon, for either RPA2A or RPA2D. 
equal to the koff (Figure 5.4 B).Therefore, the kon value of RPA2A to ssDNA is 0.3 ± 0.013 
nM-1s-1, and the kon value of RPA2D to ssDNA is 0.19 ± 0.003 nM-1s-1. These data suggest 
that the binding of RPA2A to ssDNA is faster than RPA2D at same RPA and DNA 
concentration.  
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RPA2A RPA2D 
Figure 5.5 Stop-flow kinetics measuring the koff values of RPA2A and RPA2D. 
RPA:hexachlorofluorescein-ssDNA (21-mer) (20nM:20nM) was challenged by competitor ssDNA 
(21-mer, 300 nM) (See Material and Methods). There is a time-dependent decrease in RPA: 
hexachlorofluorescein-ssDNA fluorescence (bottom trace). Each trace is an average of 12~20 shoots. The 
kinetic traces are fit to a single-exponential fit and give koff values of RPA2A and RPA2D. The residual 
values obtained for each fit of the data are presented in the panel above the kinetic traces. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Since the y-intercept approaches zero, it is difficult to calculate the koff values in this 
experiment. To detect the koff values of RPA2A and RPA2D for ssDNA, RPA:*ssDNA 
(Hexachlorofluorescein-21-mer, RPA:*ssDNA = 20nM:20nM) was challenged by ssDNA 
(21-mer, 300nM). Fluorescence was measured following excitation at 535 nm using a 
555-nm long-pass cut-on filter. The results reveal a RPA:*ssDNA-independent 
fluorescence quenching effect by ssDNA, and are shown in Figure 5.5. The data fits to a 
single-exponential decay: Y=A1*e(-k1t) + C1 (kobs = k1). The values of A1, C1, and k1 were 
calculated using KinTek software (Figure 5.5). In this experiment, [ssDNA]>>[*ssDNA], 
RPA released from RPA:*ssDNA was sequestered by ssDNA to make RPA:*ssDNA → 
RPA + *ssDNA an irreversible reaction, therefore, koff is equal to kobs. The results show 
that the koff value of RPA2A is 0.065 ± 0.02 s-1 (Figure 5.5 left panel), and the koff value of 
RPA2D is 0.378 ± 0.072 s-1 (Figure 5.5 right panel). This data suggests that RPA2D 
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dissociates from ssDNA faster than RPA2A.  
The KD (dissociation rate constant) value is equal to koff divided by kon. Therefore, 
the KD value of RPA2A is 0.216 nM, and the KD value of RPA2D is 1.77 nM. These data 
show that RPA2A has higher ssDNA binding affinity than RPA2D. Therefore, 
phosphorylation of RPA reduces its DNA binding ability of RPA by both decreasing its 
kon value and increasing its koff value. In other words, RPA2 phosphorylation increases the 
KD value of RPA. 
 
RPA2 phosphorylation might potentiate the release of RPA from DNA during gap 
filling 
    Competition and stop-flow kinetic data derived from purified RPA2A, RPA2D and 
RPA2WT suggest that phosphorylation of RPA2 decreased the ssDNA binding ability of 
RPA through increasing its koff and decreasing its kon. To test whether phosphorylated RPA 
is released from DNA more efficiently than unphosphorylated RPA during DNA 
resynthesis, a time course of gap filling by HeLa nuclear extract was performed using 
resin-bound linear dsDNA containing a 171-nt gap (See structure in Figure 5.6). RPA and 
DNA polymerase δ pulled down by the DNA were detected using Western blot, and DNA 
resynthesis products (744 nt) during this process were detected using Southern blot. As 
shown in Figure 5.6 A, RPA and DNA polymerase δ bound to gapped dsDNA, and most 
of phosphorylated RPA released from DNA (Figure 5.6 A top three panels) during DNA 
resynthesis (Figure 5.6 A bottom panel). However, in the presence of Wortmannin, 
phosphorylation of RPA2 is inhibited. As a result, RPA cannot be released from DNA as 
efficiently as phosphorylated RPA during DNA resynthesis (Figure 5.6 B top three 
panels). In this condition, RPA might compete with DNA polymerase δ for template 
binding or slow down the processing of DNA polymerase δ, thereby resulting in less 
DNA synthesis (Figure 5.6 B bottom panel, about 50% less than that of panel A after 
20-min reaction). Interestingly, when Aphidicolin, an inhibitor of DNA polymerase δ and 
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Figure 5.6 RPA2 phosphorylation potentiates RPA to be released from DNA. (A~C) Biotinylated 
linear gapped dsDNA was incubated with HeLa nuclear extract at 37°C for indicated time. RPA1, 
RPA2 and DNA polymerase δ pulled down by DNA were detected using Western blot. The bottom 
panel showed the DNA resynthesis products (744 bp, as shown in Fig. 5.1 E) using Southern blot: (A) 
Control; (B) RPA phosphorylation was inhibited by wortmannin; (C) DNA synthesis was inhibited by 
Aphidicolin. 
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ε, is added in the reaction to inhibit DNA resynthesis (Figure 5.6 C bottom panel, about 
80% less that of panel A after 20-min reaction) [119, 120], phosphorylated RPA still binds 
to the DNA (Figure 5.6 C top three panels). These data suggest that although 
phosphorylation of RPA2 decreases the ssDNA binding ability of RPA (Figure 5.3~5.5) 
and potentiates the release of RPA from DNA (Figure 5.6 A vs. Figure 5.6 B). The release 
of phosphorylated RPA from DNA is DNA resynthesis-(or DNA resynthesis enzyme) 
dependent (Figure 5.6 A vs. Figure 5.6 C) because phosphorylated RPA still has ssDNA 
binding ability (Figure 5.3~5.5).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
RPA2 is phosphorylated after RPA binds to DNA 
The pull-down assay showed that unphosphorylated RPA2 disappears from DNA 
and phosphorylated RPA2 appears on DNA after incubation at 37°C (Figure 3.4). There 
are two possible explanations for this phenomenon: either RPA2 is phosphorylated after 
RPA binds to DNA or phosphorylated RPA replaces unphosphorylated RPA during 
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incubation at 37°C.  
Western blot results show that more than 95% of RPA in HeLa nuclear extract is in 
unphosphorylated form (data not shown). The process that DNA-PK and AMT catalyzes 
RPA2 phosphorylation depends on ssDNA [144, 152] . In addition, phosphorylation of 
RPA2 reduces the ssDNA binding ability of RPA (Figure 5.4 & 5.5) and phosphorylated 
RPA cannot displace DNA-bound unphosphorylated RPA from DNA (Figure 5.4 B). 
Therefore, the disappearance of RPA2 from DNA and the appearance of phosphorylated 
RPA2 on DNA after incubation at 37°C probably indicates that RPA2 is phosphorylated 
after RPA binds to DNA. 
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DISCUSSION 
     RPA is an essential component of MMR pathway in human cells [51, 52]. It is 
required for both the excision step and DNA resynthesis step [52]. RPA binds to 
heteroduplex DNA as early as mismatch recognition, RPA2 is phosphorylated during 
MMR process, and phosphorylation of RPA2 is associated with DNA polymerase δ 
binding and the appearance of repair products (Chapter 3). It has been reported that 
phosphorylation of RPA2 occurs in response to cell cycle and DNA damage [100-105, 
146, 153]. Therefore, RPA2 phosphorylation may not be specific for the MMR pathway. 
It might be involved in a number of DNA metabolic pathways, including DNA MMR. 
Here, we demonstrate that RPA2 phosphorylation facilitates DNA polymerase 
δ-catalyzed gap filling on RPA-protected template, and phosphorylation of RPA2 reduce 
ssDNA binding ability of RPA. Therefore, the stimulation of resynthesis by RPA2 
phosphorylation is likely due to the fact that phosphorylation potentiates the release of 
RPA from DNA, thereby making DNA template available for synthesis. 
      As a ssDNA binding protein, RPA performs at least two functions in DNA 
mismatch repair. The first is that RPA stimulates mismatch excision [52, 59, 62], which 
might be due to its helix-destabilizing ("unwinding") activity [147, 154, 155]. The second 
is that RPA protects continuous (template) strand from nuclease digestion. When there is 
no RPA protection there are no repair products because the continuous (template) strand 
is destroyed by nuclease(s) [52]. However, RPA binding to DNA template slows down 
DNA resynthesis (Figure 5.1 & 5.2). Interestingly, this negative effect of RPA is 
attenuated by RPA2 phosphorylation, a process that decreases ssDNA binding ability of 
RPA (Figure 5.3~5.5). The release of phosphorylated RPA from DNA is DNA resynthesis 
(or resynthesis enzyme) dependent, suggesting that phosphorylated RPA can still bind to 
ssDNA to protect the template before it is displaced from the DNA. Considering that RPA 
is a specific component of pre-replication centers [156] and RPA2 is phosphorylated 
during DNA replication [100], we hypothesize that phosphorylation of RPA2 performs 
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similar role in DNA replication as well as in MMR.  
    A recent paper showed that RPA is required in the recruitment of ATR-ATRIP 
protein kinase complex to DNA damage sites [140]. RPA can interact with many proteins, 
such as DNA polymerase α [157], XPA, XPG and ERCC-1/XPF [158, 159], DNA-PK 
and ATM [146]. Phosphorylation of RPA2 decreases the interaction between RPA and 
these proteins [146]. Therefore, phosphorylation of RPA2 not only regulates RPA binding 
to and releasing from DNA, but may also regulate the recruitment of RPA-bound proteins 
to DNA. The binding of unphosphorylated RPA to DNA could facilitate recruitment of 
these proteins to DNA. Phosphorylation of RPA2 could help to hand off the recruited 
proteins to direct DNA processing.  
    Phosphorylation of RPA might play similar functions in vivo as demonstrated in our 
in vitro study. Furthermore, phosphorylation of RPA might serve as an apoptotic signal 
for DNA damage [160]. It is possible that in the S-phase or M-phase of cell cycle, some 
kinds of cell “unknown systems” are open; as a result, Pi-RPA is either dephosphorylated 
or degraded so that the cell keeps levels of Pi-RPA low. In other phases of cell cycle, the 
“systems” are closed, and once DNA is damaged at this time, RPA would participate in 
DNA damage repair, and RPA2 is phosphorylated during this process. If damage is so 
serious that high level of Pi-RPA is induced, which overwhelms the cells’ clearance 
ability, apoptotic pathway would be activated and the cells would go into apoptosis.    
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CHAPTER 6. Summary and Speculations 
 
6.1 Summary of findings 
MMR is composed of multiple-step reactions performed by multiple proteins [41, 42, 
44, 49, 52-54, 73, 121]. The results presented here describe how the binding and 
modification of these proteins is related to the processing of heteroduplex by MMR 
system. These data are particularly directed towards understanding how PCNA functions 
in 3’ and 5’ mismatch excision, and how RPA2 phosphorylation affects DNA resynthesis. 
 
6.1.1 Sequential events of DNA mismatch repair  
We constructed biotinylated nicked linear mismatch substrate, and confirm that the 
repair of linear heteroduplex DNA is mismatch repair system dependent. Using this 
substrate to perform MMR assay, mismatch excision assay and protein pull-down assay, 
we demonstrate sequential events of DNA mismatch repair (table 6.1). The repair 
products appear at 6 min after incubation at 37°C. The mismatch-provoked excision starts 
at 2 min, and extensive excision is detected at 4 min. The excision is immediately 
followed by repair resynthesis. At the protein level, it was found that MutSα, MutLα, and 
PCNA bound to the DNA substrate as early as 0.5 min after incubation at 37°C, and the 
amount of these proteins increased as the MMR reaction process, suggesting that these 
proteins are involved in MMR initiation. The binding of DNA polymerase δ to the DNA 
substrate is detected at ~4 min, indicating than DNA resynthesis started at this time point. 
In addition, dramatic increase of PCNA binding to DNA was associated with the 
appearance and increase of mismatch excision intermediates, indicating that PCNA might 
perform a role during mismatch excision. Surprisingly, RPA bound to the DNA substrate 
earlier than the initiation factor, and was constantly associated with the DNA molecules. 
More strikingly, RPA2 (the 32-kD subunit) was phosphorylated during MMR process. 
The temporal relationship between RPA2 phosphorylation and the binding of DNA 
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polymerase δ to the DNA substrate suggests that RPA phosphorylation might play a role 
in repair DNA resynthesis. 
 
 
 
 
 
 
 
 
 
 
 
Moreover, our in vitro studies further confirm that unlike MutSα and MutLα, DNA 
polymerase δ, PCNA and RPA are not specific for MMR, although they are required by 
MMR [2, 3, 6, 7]. These proteins in HeLa nuclear extract bind to both heteroduplex and 
homoduplex nicked substrates.  
 
6.1.2 Different roles of PCNA in 5’ nick and 3’ nick directed MMR 
As a DNA polymerase processing factor, PCNA is a critical component in MMR in 
human cells [56, 121]. However, considering that DNA MMR might be a DNA 
replication-coupled process [3], and that mismatched bases could be incorporated into 
either leading or lagging strand, the repair of these mismatch bases produced during DNA 
replication could be in either 3’ nick- or 5’ nick-directed way. Here, we demonstrate the 
differential requirements for PCNA in 5’ nick and 3’ nick mismatch-directed excision. 
Our observations are supported by experiments using the purified MMR recombinant 
system [59, 62]. 
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PCNA is absolutely required by DNA resynthesis step of both 3’ and 5’ mismatch 
substrate. However, the requirement for PCNA in 5’ nicked- and 3’ nicked-directed 
mismatch-provoked excision is different. 3’ nicked mismatch DNA (7.3 kb) is excised in 
two ways: 3’→5’ mismatch excision and 5’→3’ mismatch-independent excision. PCNA 
is required for both. However, 5’ nicked mismatch DNA (6.4 kb) is excised in three ways: 
5’→3’ mismatch-directed PCNA-independent excision, 5’→3’ mismatch-directed 
PCNA-dependent excision, and 5’→3’ PCNA-dependent homoduplex excision (Figure 
6.1). According to Modrich and co-workers’ studies, Exo1, a 5’→3’ exonuclease, can 
perform 5’→3’ mismatch excision in a PCNA-independent way [49, 62]; and also can 
also perform 3’→5’ PCNA- and RFC-dependent mismatch excision [59].  
  
 
 
 
 
 
 
 
6.1.3 RPA2 phosphorylation speeds up “RPA cycle” during DNA repair 
    RPA2, one of RPA subunits, is phosphorylated corresponding to cell cycle (S-phase 
and M-phase) and DNA damage. The function of RPA2 phosphorylation in DNA 
metabolism is unclear. By using series of biotinylated dsDNA to perform RPA pull-down 
assay, we demonstrate that RPA perform its function in the following way: (1) RPA binds 
to dsDNA containing a nick or gap; (2) after binding, RPA2 is phosphorylated; (3) 
Figure 6.1 Involvement of PCNA in 5’ and 3’ mismatch repair. Blue color: 3’ mismatch-dependent 
mismatch excision (1), 5’ PCNA-dependent homoduplex excision (3), 5’ PCNA-dependent mismatch 
excision (4), and DNA resynthesis. Red color: 5’ PCNA-independent mismatch excision (2).  
 
(4) 
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phosphorylation of RPA2 decreases the ssDNA binding ability of RPA to potentiate the 
release of phosphorylated RPA from DNA, but the release of phosphorylated RPA is 
dependent on the enzyme(s) involved in DNA resynthesis. We do not know the fate of 
Pi-RPA after being released from DNA. It might dissociate into free subunits, or form 
into a stable complex, or be degraded. According to this model (Figure 6.2), RPA2 
phosphorylation speeds up the “RPA cycle” during DNA repair. 
 
 
 
 
 
 
 
 
 
 
 
6.1.4 RPA2 phosphorylation facilitates gap filling on RPA-protected template 
As an ssDNA-binding protein in human cell, RPA performs at least two functions in 
MMR: stimulating mismatch excision and protecting template from nuclease digestion. 
Because of its higher DNA binding ability and helix-destabilizing ("unwinding") activity, 
RPA binds to nicked heteroduplex DNA to perform these functions efficiently. However, 
in the DNA resynthesis step, RPA-protected template must be available for DNA 
polymerase δ. Our data demonstrate that phosphorylation of RPA2 facilitates gap filling 
on RPA-protected template. One possible mechanism might be that RPA2 
phosphorylation reduces the ssDNA binding ability of RPA to potentiate the release of 
RPA from DNA, thereby making sure that DNA polymerase δ can move along 
Figure 6.2 The model for RPA2 phosphorylation in “RPA cycle”. (1) During DNA 
metabolism, nick or gap is produced. (2) RPA binds to dsDNA containing nick or gap. (3) After 
binding, one of RPA’s subunits, RPA2 is phosphorylated. (4) Phosphorylation of RPA2 
potentiates the release of RPA from DNA during DNA metabolism.  
 - 80 -
phosphorylated RPA-bound template smoothly during DNA resynthesis.  
6.2 Further Studies 
    Our studies here demonstrate how mismatch substrates are processed by MMR 
system in vitro step by step, especially how PCNA and RPA perform their function during 
these processes. Some of our other observations could give us important directions for 
further studies. 
 
6.2.1 To look for the novel components involved in MMR  
    To date, the components of MMR system are not fully identified, i.e. more 
exonucleases may be involved. In this study, a series of biotinylated dsDNA substrates 
were constructed. These substrates could be processed by HeLa nuclear extract and 
pulled down by streptavidin beads. Therefore, the difference of the proteins pulled down 
by heteroduplex and homoduplex was compared to look for the protein(s) specific for 
heteroduplex processing. Protein pull-down results show that two proteins bind to linear 
5’ nicked heteroduplex dsDNA specifically. The molecular weight of these proteins are 
about 40 kD and 95~100 kD. In future studies, we would determine the identities of these 
proteins as well as their function in DNA MMR. 
 
6.2.2 To study whether and how RPA affects mismatch excision pattern 
    RPA binds to ssDNA beginning at the 5’ end and proceeding 3’ [161, 162] and each 
RPA binds to about 30 nt to form stable RPA30nt [143, 163]. RPA is required for MMR 
excision [52]. Here, we find that RPA binds to nicked heteroduplex DNA as early as 
mismatch recognition for both 5’ and 3’ substrates, however, the mismatch excision patter 
for 5’ and 3’ substrates is different. In 5’ substrate, the excision intermediates are in a 
quantum manner, and the distance between each excision band is about 29 nt, which is 
very close to the length of nucleotides that is required for the formation of stable RPA30nt. 
(Figure 6.3 E.I.). In 3’ substrate, the excision intermediates do not show this kind of even 
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Figure 6.3 Excision fragments of 5’ nicked 
G/T substrate. Excision products of 5’ nicked 
G/T were digested by SspI, separated using
sequencing gel, and detected using Southern 
blot.  M: 32Pi-labelled 100 bp ladders. S: 
f1MR1 fragments cut by either Sau96I & SspI 
(544 bp) or HindIII and SspI (414 bp). E.I.: 
Excision intermediates. 
pattern. We hypothesize that the polarity of RPA for DNA binding might cause the 
difference of 5’ and 3’ mismatch excision. Next, we would try to use purified MMR 
recombinant system to test how RPA affects 5’ and 3’ mismatch excision.  
 
 
 
 
 
 
 
  
 
 
6.2.3 To test whether DNA MMR is a DNA replication-coupled process in human cell 
    No MutH homolog is identified in human cell. It is possible that DNA MMR in 
human cells might be exclusively a DNA replication-coupled process [3]. To test this, we 
would perform both in vitro pull-down assay and in vivo CHIP assay. The results might 
tell us the specificity of MutSα and MutLα for DNA binding in vitro, and the relationship 
between MutSα & MutLα binding to DNA and cell cycle in vivo. These data could 
indicate that whether DNA MMR in human cells is a DNA replication-coupled process. 
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APPENDIX 
 
A adenine 
ATM  ataxia-telangiectasia mutated protein kinase 
ATP adenosine triphosphate 
ATR ataxia-telangiectasia mutated and Rad3-related 
ATRIP  ATR-interacting protein 
bp base pair (s) 
β-ME β-mercaptoethanol 
C Complementary Strand; cytosine 
Cdk cyclin-dependent kinase 
dNTP deoxy nucleotides triphosphate 
DNA-PK DNA-dependent protein kinase 
DTT dithiothreitol 
dsDNA double-stranded DNA 
EDTA  ethylenediamine tretracetic acid  
ERCC excision repair cross complementing 
ERCC-1  Excision repair cross-complementation1 
EtBr ethidium bromide 
FBS fetal bovine serum 
FEN-1 flap endonuclease 1 
G guanine 
GST  glutathione-S-transferase  
HNPCC hereditary non-polyposis colorectal cancer 
MLH  MutL homolog 
MMR mismatch repair 
MNNG  N-methyl-N'-nitro-N-nitrosoguanidine 
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MNU  N-methyl-N-nitrosourea 
MSH MutS homolog 
MSI microsatellite sequence instability 
MutLα Complex of MLH1 and PMS2 (human) or PMS1 (yeast) 
MutSα Complex of MSH2 and MSH6 
MutSβ Complex of MSH2 and MSH3 
nt nucleotide 
PAGE polyacrylamide gel electrophoresis 
PCNA proliferating cell nuclear antigen 
PMS  post meiotic segregation 
RFC replication factor C 
RPA replication protein A (unphosphorylated RPA) 
ssDNA single stranded DNA 
SDS sodium dodecyl sulfate 
T thymine 
UV ultraviolet 
V Viral strand 
XP Xeroderma pigmentosum 
XPA Xeroderma pigmentosum A 
XPG Xeroderma pigmentosum G 
XPF  Xeroderma pigmentosum F  
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